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IAbstract
Helicteres angustifolia L. (H. angustifolia), a traditional medicinal plan, is widely
distributed in China, Laos, and Japan. It has long been used as remedy against various
types of illness relating to oxidation and immune response, such as diabetes,
inflammations and fever. Previous works mainly focused on the isolation, determination
and bioactivities identification of quinones, triterpenoids, lignins, and alkaloids from this
plant. Up to the present, however, limit information is available on the characterization,
and identification of antioxidant and immunomodulatory activity of its polysaccharides.
In this study, the in vivo immune enhancement ability of crude polysaccharide from
H. angustifolia (HACP) was identified by using 4T1 breast tumor BALB/c mice. The
major bioactive fractions of HACP was then purified stepwise successfully with DEAE
Sepharose Fast Flow and Sephacry S-400 chromatography. The primary structure features
and molecular weight of the obtained fractions were determined. Moreover, in vitro
antioxidant and macrophages activation abilities were also evaluated.
After orally administering HACP to 4T1 tumor-bearing mice for continuous 15 days,
the mice immune response was found significantly (p < 0.05) improved. Especially, 300
mg/kg of HACP treatment increased mouse spleen indices, CD4+ and CD8+ ratios about
1.9, 2.0, and 1.4 times compared to the tumor control group. The increased immune
response resulted in a reduced tumor weight and lung metastasis, with inhibition rates of
67.7% and 13.7%, respectively. Three major bioactive fractions were then fractionated
and purified from HACP, yielding 7.4%, 6.9% and 9.8% of the total amount of HACP,
respectively. Physicochemical analysis demonstrates that SPF1-1, SPF2-1, and SPF3-1 are
typical pectic polysaccharides which have different molecular weights and structure
features.
Among the three SPF fractions, significant high arabinose and relative higher
galactose and xylose levels were detected in SPF3-1, highly correlating with DPPH
radical inhibition effect, reducing power and metal chelating activity. In vitro
immunomodulatory assay demonstrates that the fraction SPF3-1 with the highest uronic
acid content (58.8%) and lowest molecular weight (13.36 kD) has been proven to possess
the highest immunomodulatory activities, this observation is attributable to the significant
(p < 0.05) proliferation and phagocytic capacity of macrophage cells. In addition,
remarkably releases of IL-6 and TNF-α were detected in SPF3-1 treated cells in a
dose-dependent manner. Furthermore, SPF3-1 was found to possess obvious induction
II
effect on lymphocytes proliferation, with the highest viability increased to 196% after 100
μg/mL of SPF3-1 treatment for 48 h, indicating its potent lymphocyte activation function.
Moreover, 100 μg/mL of SPF3-1 treatment efficiently promoted lymphocytes IL-6 and
IFN-γ release (117.3 and 63.6 pg/mL), significantly higher than the control groups (36.8
pg/mL and 21.0 pg/mL).
In conclusion, HACP from H. angustifolia exhibit potent antioxidant and
immunomodulatory activity in vivo. Fraction SPF3-1 with higher antioxidant and
macrophages activation abilities could be further developed as new products for
medicines or functional foods.
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1Chapter 1 Introduction
1.1. Polysaccharide
Polysaccharide is a kind of polymeric carbohydrates consisting more than ten of
monosaccharides linked by glyosidic bonds. Being widely existed in plants, animals, algae,
and microorganisms, play important roles in cell adhesion, cell-cell communication, and
molecular recognition (Yu et al., 2018).
1.1.1. The structure of polysaccharide
Based on the numbers of monosaccharide types present in the molecule, the
polysaccharides are classified into two types, homo-polysaccharides (homoglycans) and
hetero-polysaccharides (heteroglycans). Homoglycans are polysaccharides which consist
of a single type of monosaccharide, such as cellulose (Liu, Willfor, & Xu, 2015). On the
other hand, polysaccharides such as hyaluronic acid, which made up of more than one type
of monosaccharide are called heteroglycans. According to the glycosides linked onto the
glycan, polysaccharides can also be classified as glycoproteins, glycolipids, proteoglycans,
and glycoconjugates (Berg, Tymoczko, & Stryer, 2012).
Unlike other biopolymers, polysaccharides can exist in both a linear structural form
and branched forms. The structural type of a polysaccharide largely determines its
physicochemical properties, particularly solubility in water. Regular linear polysaccharides,
such as cellulose, are insoluble in water since the energy of molecular interaction is greater
than the hydration energy. Highly branched polysaccharides that do not have an ordered
structure are readily soluble in water.
1.1.2. Bioactive polysaccharides in herbs
In traditional Chinese medicines, herbs have been used to treat various types of illness.
It has been identified as one of the major active ingredients responsible for various
pharmacological activities, such as immunomodulatory activity, antiviral activity,
antioxidant activity, antitumor activity, hepatoprotection effect, and antifatigue effect
(Harlev, Nevo, Lansky, Ofir, & Bishayee, 2012; Jin, Huang, Zhao, & Shang, 2013; Li &
Peng, 2013; Tian, Zhao, Guo, & Yang, 2011; Tang, Hemm, & Bertram, 2003a). According
to China Food and Drug Administration (CFDA), there are 38 kinds of drugs and 85 kinds
of healthcare products are composed of polysaccharides. Some specific drugs and products
are summarized in Table 1-1.
1.1.3. The antioxidant and immunomodulatory activities of polysaccharides
2In recent years, polysaccharides from natural sources have attracted increasing
attention due to their wide variety of pharmacological activities and non-toxic properties
(Huang, Zhao, & Shang, 2013; Liu et al., 2018; Meng et al., 2016；Nie et al., 2018;).
Specifically, pectic polysaccharide, and galactomannan isolated from higher plant have
been all proved to possess antioxidant and immunomodulatory activities (Di et al., 2017;
Wang et al., 2013; Yu et al., 2018)
Immunomodulation is one of the important defense properties for body preventing
infections, inflammatory diseases, and cancer (Yu et al., 2018). The first report related to
polysaccharides with immune activity were those antigenic polysaccharides from bacteria
(Morgan, 1936). After these, polysaccharides from plants, animals, and algae with less
toxic were progressively studied (Ramberg et al., 2010; Schepetkin & Quin, 2006).
Nowadays, immunomodulatory polysaccharides from natural resources has been the hot
topic of research. Pectic polysaccharides, glucans, arabinogalactans, and xylans are the
most studied polysaccharides concerning their possible immunomodulatory activity (Fig.
1-2). It is reported that sulfated polysaccharide obtained from Cyclocarya paiurus
significantly enhanced the TNF- α and IL-6 cytokines production in macrophages in a
dose-dependent manner (Yu et. al., 2017). Juniperus scopolorum cones polysaccharide was
found to direct stimulate NO generation via induction of NO synthase (Schepetkin et al.,
2005). A study published by Jin et al. (2008) also state that sulfated Achyranthes bidentata
polysaccharides can increase the proliferation of splenic lymphocytes in a concentration
dependent manner, enhance the levels of cytokines IL-2 and TNF-α as well.
As it is well known, increased free radicals in the body will lead to T cell damage, and
decreased immune function. Therefore, discovery and evaluation of substance with
antioxidant properties have been paid more and more attention in biology and medicine.
Studies have found that some polysaccharides derived from higher plant can inhibit lipid
peroxidation, enhance the body’s ability to scavenge free radicals, and inhibition of
oxidation disease (Wang et al., 2017). For example, Algal polysaccharides have been
demonstrated to play an important role in preventing the oxidative damage in living
organisms (Cristina Diaz et al., 2017). Three polysaccharides (GLP-H, GLP-V and GLP-F)
isolated from Ganoderma lucidum showed the stronger radical scavenging activities and
was proved that exhibited antioxidant activities in vitro (Fan, Li, Deng, & Ai, 2012).
Further, administration of litchi pulp polysaccharide (50-200 mg/kg/d) was found to
remarkably enhanced the total antioxidant capacity, as well as superoxidase dismutase
3activity in the serum and liver of cyclophosphamide-induced mice (Huang et al., 2016).
1.2. Helicteres angustifolia L.
Helicteres angustifolia L. (H. angustifolia) (Fig.1-1), with brown color and bitter taste,
belonging to the family Sterculiaceae, is a traditional medicinal herb widely distributed in
southern China, Laos, and Japan. So far, this plant has been widely used as a remedy
against various types of illness, such as cold, headache, inflammations and fever in China
(Chang et al., 2001) and diabetes treatment in Laos.
1.2.1. Phytochemical composition of H. angustifolia
Previous phytochemical research of this plant has been focused on isolation, analysis
or determination of quinones, triterpenoids (Chen et al., 1990；Pan et al., 2008), lignans,
flavonoids, and alkaloids (Wang et al., 2012). In a previous study reported by Wang & Liu
(1987), dried roots of H. angustifolia were extracted with EtOH, after that, the
EtOAc-soluble portion was packed on the top of a silica gel column. A new
naphthoquinone named helicquinone was then isolated from this fraction, and its structure
was found to be 2,3-dihydro-8-hydroxy-3,5,6-trimethynaphtho (2,3-b) furan-4,9-dione on
the basis of spectroscopic evidence. Chen et al (1990) isolated four sesquiterpenoid
quinones from the root bark of H. angustifolia which were identified as mansonones E, F,
H, and M. In 2001, three lupine type triterpenoids, methyl helicterate,
3-acetoxy-27-benzoyloxylup-20(29)-en-28-oic acid, and 3β-acetoxy-27-(p-hydroxyl)
benzoyloxylup-20(29)-en-28-oic acid methyl ester were isolated from the CH2Cl2 fraction
of the MeOH extracts of H. angustifolia root. In addition, four new compounds, including
2α, 7β, 20α-Trihydroxy-3β, 21-dimethoxy-5-pregnene (1), 6, 7, 9α-trihydroxy-3, 8,
11α-trimethylcyclohexo-[d, e]-coumarin (2), 3β-hydroxy-27-benzoyloxylup-20
(29)-en-28-oic acid (3), and 3β-hydroxy-27-benzoyloxylup-20(29)-en-28-oic acid methyl
ester (4) along with other 24 known compounds (including triterpenoids, lignans and
phenolic compounds ) were isolated and structure characterized from roots of H.
angustifolia (Chen et al., 2006). Most recently, along with thirteen known compounds,
Wang et al. (2012) isolated two new pregnane derivatives, heligenin A-B, and a new
quinolone alkaloid (helicterine A) from the ethanol extract of the root of H. angustifolia
(Table 1-2).
1.2.2. Pharmacological activity of H. angustifolia
Various traditional uses of H. angustifolia have lead researchers to investigate its
bioactivities. Several pharmacological activities have been reported to be exhibited by
4extracts as well as single compounds of H. angustifolia, such as antioxidant, antivirus,
anti-diabetic, and anticancer. In 2008, Pan et al. reported three triterpenoids isolated from
H. angustifolia exhibited remarkable cytotoxic activities against human colorectal cancer
cells COLO 205 and gastric cancer cells AGS in vitro. In addition, Li et al. (2015) reported
that the continuous treatment with the aqueous extract of H. angustifolia resulted in a
significant reduction of tumor progression in HT1080 tumor bearing BALB/c nu mice.
Further, a triterpenoid methyl helicterate (MH) isolated from H. angustifolia significantly
decreased the levels of HBV DNA and cccDNA in the HBV-transfected cell line
HepG2.2.15, which may contribute to the anti-HBV effect of H. angustifolia (Huang et al.,
2013). Further, Li et al. (2015) investigated the free radicals (DPPH, ABTS, and OH ・
radicals) scavenging activities of aqueous and ethanol extracts of H. angustifolia. The
study stated that the extracts displayed high activities in the assays tested. Most recently,
the potential anti-diabetic effect of aqueous extract was identified by Hu et al. (2016), the
result state that aqueous root extract from H. angustifolia efficiently enhanced glucose
consumption in C2C12 myotubes and suppressed the increase of blood glucose levels in
diabetic rats.
1.3. Target and structure of the thesis
H. angustifolia has received considerable attention as functional biomaterial for
pharmaceutical and functional foods applications owing to its various biological activities.
Previous works mainly focused on the isolation, determination and bioactivities
identification of quinones, triterpenoids, lignins, and alkaloids from this plant. Up to the
present, however, limit information is available on the bioactivity identification of its
polysaccharides. An evidence from our previous study (Li et al., 2016) demonstrated that
the polysaccharide rich fraction was found to exhibit significant antioxidant activity and
play a major role in the immunomodulatory activity of this plant. Thus, proper isolation of
native bioactive polysaccharides from H. angustifolia, evaluate the antioxidant and
immunomodulatory activity both in vitro and in vivo, and determination of their structural
features are the main targets of this study.
To achieve these objectives, the thesis was divided into five chapters.
Chapter 1 Introduction
In this chapter, the background of this research was introduced, including the
introduction of polysaccharide, the structure, antioxidant and immunomodulatory activities
of polysaccharides. In addition, state the phytochemical composition as well as the
5pharmacological activity of H. angustifolia.
Chapter 2 Immunomodulatory activity of polysaccharides from H.
angustifolia against breast cancer
In this chapter, a 4T1 breast tumor model in BALB/c mice was used to evaluate the in
vivo immunomodulatory activity of HACP. Mice were orally administered with 100, 200,
and 300 mg/kg of HACP for 15 days. At the end of the experiment, the tumor size changes,
immune organ indices, CD4+/CD8+ ratios in spleen lymphocytes, and the
immunomodulatory cytokines productions in the serum of tumor-bearing mice were
determined.
Chapter 3 Purification and characterization of polysaccharide fractions
from HACP
In this chapter, HACP was separated and purified into three fractions by using DEAE
Sepharose Fast Flow and Sephacryl S-400 chromatography. The surface structure,
monosaccharide composition and molecular weight of obtained fractions were identified.
Chapter 4 In vitro antioxidant and immunomodulatory effects of
polysaccharide fractions
In this chapter, the in vitro antioxidant and macrophage cell activation ability of
fractions SPF1-1, SPF2-1, and SPF3-1 were investigated. In addition, the relationships
between polysaccharide structure and bioactivities are analysed as well.
Chapter 5 Conclusions and future researches
In this chapter, the main results were summarized, and the expected utilization of
polysaccharides from H. angustifolia is put forward. In particular, the future study research
of the polysaccharides was directed.
6Table 1- 1 Polysaccharide drugs and healthy products of commercially available
Resource Polysaccharide Listed drugs
Plant Ginseng polysaccharide Ginseng Polysaccharide Injectionnn
Astragalus polysaccharide Astragalus polysaccharide injection
Microbal Lentinan Lentinan lnjection; Lentinan capsules;
Lentinus Edodes; Mycelia Polysacharide
Tablets
Poria polysaccharide Poria polysaccharide oral solution
Ganoderma lucidum polysaccharide Ganoderma lucidum polysaccharide capsules
Dextran Dextran 40 Glucose injection; Dextran 70
eye drops; Low molecule dextran
Animal Chondroitin sulfate Chondroitin Sulfate Tablets; Chondroitin
sulfate
(Chondroitin sulfate A sodium) capsules;
Chondroitin sulfate (Chondroitin sulfate A
sodium) injection
Hyaluronic acid Sodium hyaluronate injection; Sodium
Hyaluronate Eye Drops
(Yu,Y., Shen, M., Song, Q., & Xie, J., 2018).
7Table 1- 2 Phytochemical composition of H. angustifolia
Compound name References
Triterpenoids 3β-Ο-
(trans-coumaroyl)betulinic acid
Chang, Ku et al. 2001
3β-Ο-(trans-feruloyl)betulinic acid
3β-Ο-(trans-coumar-
oyl)betulin
3β-Ο-(cis-coumaroyl)betulin
3β-Ο-(trans-caffeoyl)betulin
3β-Ο-(trans-feruloyl)betulin
methyl helicterilate
methyl helicterate
helicterilic acid
cylicodiscic acid
oleanolic acid
pyracrenic acid
cucurbitacin D
cucurbitacin J
Naphthoquinone heliquinone Wang and Liu 1987
Mansonone mansonone E Chen et al. 1990
mansonone F
mansonone H
Steroids β-sitosterol
Alkaloid heligenin A Wang, Li et al. 2012
heligenin B
helicterone A
Flavonoid potengriffioside A Chen, Tang et al. 2006
Lignin (7S,8R)-urolignoside
(7S,8R)-dihydrodehydrodiconiferyl
alcohol
Phenolic compounds rosmarinic acid
protocatechuic aldehyde
8Figure 1- 1 H. angustifolia used in this study
9Figure 1- 2 Number of papers with the topics “polysaccharides and immunostimulatory”
These searches cover papers from 1936 until 2014.
(Ferreira, S. S. et al., 2015)
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Chapter 2 Immunomodulatory activity of polysaccharides from H.
angustifolia against breast cancer
2.1. Introduction
Every year, more than 2 million women are diagnosed with breast cancer worldwide,
making it the second-leading cause of cancer-related death and the most common cancer
among women worldwide. It is reported that about one in five women would die from this
disease (Ginsburg et al., 2017；Gupta et al., 2012). The mortality of breast cancer usually
results from the tumor metastatic spread to other organs, and the most common sites are
the bone, followed by the lung and liver. Chemotherapy is one of the most commonly
applied therapeutic modalities for breast cancer treatment. However, the chemotherapeutic
agents used in the treatment are usually toxic to normal cells (Sun et al., 2014). Currently,
accumulating evidence strongly suggests that the immune system plays a decisive role in
controlling cancer development and progression (Ren et al., 2012；Wang et al., 2017),
making the discovery of novel compounds with specific immunomodulatory activity and
less toxicity of current interest to cancer researchers.
H. angustifolia has long been used as remedy to treat various diseases related to
immune response. Its phytochemistry and pharmacological properties including
antioxidation, antidiabetic, antiviral and anticancer activities have been already mentioned
in chapter 1. Additionally, the polysaccharide-rich fraction from the aqueous extract of H.
angustifolia has been found to have immunomodulatory activity in vitro in our very recent
study (Li et al., 2016). Up to the present, however, whether the polysaccharide from H.
angustifolia can regulate the immune system in vivo has not been disclosed yet.
2.2. Materials and methods
2.2.1. Plant material and chemicals
RPMI-1640 medium and fetal-calf serum was obtained from Gibco Life Technologies
(Grand Island, NY, USA). FITC-anti-mouse-CD4 and PE-anti-mouse-CD8 antibodies, and
Mouse TNF-α, IL-1β, IFN-γ and IL-6 ELISA Kits were purchased from eBioscience (San
Diego, CA, USA). CD34 primary antibody was from BD Pharmingen (San Jose, CA). The
assay kits for superoxide dismutase (SOD) and CCK-8 were from Dojindo Molecular
Technologies (Japan), and the CAT activity kit KO33-H1 was obtained from Arbor Assays
(USA). Thiobarbituric acid reactive substance (TBARS) kit FR40 was purchased from
Oxford Biomedical Research (USA). Red blood cell lysis buffer was purchased from
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Sigma Aldrich, Inc. (Saint Louis, MO, USA). All the reagents used in this study were of
analytical grade.
2.2.2. Polysaccharide extraction
The dry root powder of H. angustifolia (100 g) was defatted as described earlier
(Wang et al., 2016). The defatted residue was then extracted with distilled water at 100C
for 3 h at a ratio of 1:10 (w/v). After 3 repetitions, the supernatant was collected, filtered,
concentrated and mixed with 4 times of ethanol overnight at 4C. This step was repeated
three times to thoroughly remove the soluble ethanol. The resultant precipitate was
deproteinized using the Sevag method, and the final solution was lyophilized to obtain the
H. angustifolia crude polysaccharide (HACP).
2.2.3. Determination of chemical composition
The total phenolic content was determined using Folin-Ciocalteu reagent with Gallic
acid as the standard. 0.1 mL of HACP were mixed with 0.4 mL of distilled water, and
Folin–Ciocalteu reagent (1 mL) was added. After 3 min incubation, added 0.3 mL Na2CO3
(20%), the mixture was kept in the dark for 90 min. At last, the OD of the mixture was read
at 725 nm using a UV- spectrophotometer. The total polyphenol content was expressed in
milligrams of Gallic acid equivalents (GAE) per gram of the sample.
The total polysaccharide content of HACP was detected by using the phenol-sulfuric
acid method (DuBois et al., 1956). The uronic acid content of SPF3-1 was determined by
modified carbazole method according to a previous research (Bitter & Muir, 1962). And
the protein content was determined with the protein quantification kit according to the
manufacture procedure.
2.2.4. Cell culture
Mouse mammary tumor cell line 4T1 was purchased from Riken Cell Bank (Tsukuba,
Japan). Cells were cultured in RPMI-1640 media supplemented with 10% FBS, penicillin
(100 U/mL) and streptomycin (100 µg/mL) at 37C in a 5% CO2 incubator.
2.2.5. Cytotoxicity effect on 4T1 cells
To determine the cytotoxicity of HACP on 4T1 cells, the MTT assay was employed
as described previously (Li et al., 2016). After 4T1 cells (1 × 105 cell/well) were seeded
into a 96-well plate, the cells were incubated with various concentrations of HACP for 48 h
(12.5-400 μg/mL). The cell viability was determined at 450 nm using a Model 550
microplate reader (BIO-RED, Tokyo, Japan).
2.2.6. Sub-acute toxicity study
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Five-week-old female BALB/c mice were purchased from Beijing HFK Bioscience
Co., Ltd. (Beijing, China). The mice were maintained under controlled conditions with a
constant temperature of 23 ± 1°C, humidity of 55 ± 5% and a 12 h light/dark cycle. The
mice were acclimatized for 1 week before being used for the experiment.
Female BALB/c mice (6 weeks old), weighing 17 ± 0.5 g, were orally administered
with 1000 mg/kg of HACP (0.2 mL, every day) for 15 days. During the treatment period,
mice were observed daily for any sign of toxicity, and their body weights were examined
once every three days.
2.2.7. Design for mouse experiment
In total, thirty mice of 6 weeks of age were used in this experiment. 4T1 cells (5 × 105
cells resuspended in 200 μL PBS) were subcutaneously (s.c.) inoculated at the mammary
fat pad of the mice (24 mice were used in total), and the remaining 6 mice were recognized
as Group 1, namely, the normal control group. Six days after tumor cell inoculation, the
tumor-injected mice were randomly divided into four other groups (n = 6): (1) Group 2:
tumor control group; (2) Group 3: 100 mg/kg of HACP; (3) Group 4: 200 mg/kg of HACP;
and (5) Group 5: 300 mg/kg of HACP. That is, HACP was administered orally to each
group at different dosages (100, 200, and 300 mg/kg) in the three HACP treated groups,
respectively. The tumor control (Group 2) and normal control groups (Group 1) were
treated with distilled water. All the treatments lasted for 15 days. The body weight and
tumor volume of each mouse were measured once every three days. The volume of the
tumor was calculated using the following formula: V (mm3) = (a × b2) / 2 (Collins & Yuan
et al., 2003), where a and b represent the maximum and minimum diameter (mm),
respectively. On day 21, the blood of each animal was collected from the eyeball for
further analysis. Meanwhile, organs, such as the tumor, lung, spleen and thymus, were
removed from each mouse, weighed, and sampled for further use. Spleen and thymus
indices were calculated according to the following equation：organ index = weight of organ
(mg) / body weight (g) (Huang et al., 2016).
2.2.8. Histopathology staining
Tumor tissues and lungs were fixed in 10% formalin. The tissues were then cut into
3-mm-thick sections and subjected to histology analysis with hematoxylin and eosin (H&E)
staining. To detect the microvessel density in the tumors, slides were also processed for
CD34 staining as described previously (Pan et al., 2015). Tumor burden in the lungs was
measured using ImageJ (NIH, USA) as described by Luo et al. ( 2014).
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2.2.9. Determination of spleen lymphocyte phenotype
The spleen lymphocytes were isolated as described previously (Zhang et al., 2017)
with some modifications. The spleens from each mouse were collected under aseptic
conditions. After washing with cold PBS 2 times, the spleens were scraped by glass pieces
in a cell culture plate containing 2 mL of PBS. The cells were then passed through a
200-μm cell mesh to obtain a single cell suspension. After centrifugation, red blood cell
lysis buffer was used to remove erythrocytes, and the splenic lymphocytes were washed
and re-suspended in RPMI 1640 medium. Cell viability (over 90%) was assessed
microscopically by trypan blue dye. The single splenocyte suspensions were adjusted to 1
× 106 cells/mL, and immunostained with 0.25 μg FITC-CD4+ and PE-CD8+ antibodies
under dark conditions for 30 min. After incubation, the lymphocytes were rinsed three
times with 2 mL of PBS and centrifuged at 1500 rpm for 5 min. Thereafter, the CD4+ and
CD8+-cell populations were analyzed with a FACScan flow cytometer (Becton Dickinson,
San Jose, CA).
2.2.10. Antioxidant enzyme activities and cytokines production in mice serum
The blood samples of each mouse were centrifuged for 20 minutes at 3000 rpm and
4ºC to obtain the serum. The TNF-α, IL-1β, IFN-γ, and IL-6 productions in the serum were
identified using commercial ELISA kits according to the manufacturer’s instructions. And
the antioxidant enzymes of Catalase (CAT), superoxide dismutase (SOD), and
malondialdehyde (MDA) levels in the mice serum were measured by colorimetric assay
kits according to the manufacturer’s instructions.
2.2.11. Splenocytes proliferation and natural killer (NK) cell activity
The splenocytes proliferation was determined according to a previous study (Huang et
al., 2016). 100 μL of splenocytes from each mice group were seeded into a 96-well plate (5
× 106 cell/well) and cultured for 48 h at 37ºC in a 5% CO2 incubator. The cell viability was
identified by a CCK-8 assay.
The NK cell activity was identified according to previous literature (Tu et al., 2008).
Briefly, the target cells (4T1 cells, 2 × 104 cells/well) were seeded in a 96-well plate. Then,
splenocytes from each animal group were added into each well (1 × 106 cells/well) and
used as effector cells. After incubation for 24 h, the cell viability was identified using a
CCK-8 assay (Li et al., 2017). The NK cell activity was calculated using the following
equation: NK cell activity (%) = 100 × (ODT - (ODS - ODE)) / ODT, where ODT means the
optical density of the target control cells, ODS is the optical density of the tested sample,
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and ODE is the optical density of the effector cell control.
2.2.12. Statistical analysis
All the data were expressed as the mean ± standard deviation (SD), and the results
were taken from at least three independent experiments performed in triplicate. In addition,
the data were analyzed using one-way analysis of variance (ANOVA) with Duncan’s
multiple-range test. p < 0.05 was considered statistically significant.
2.3. Results and discussion
2.3.1. Chemical composition of HACP
In this Chapter, the crud polysaccharide HACP was extracted from H. angustifolia
with a yield of 4.04%. Chemical composition analysis indicated that HACP contains
50.32% polysaccharide, 5.62% protein, and 9.66% total phenolic compounds.
2.3.2. Non-toxicity of HACP on 4T1 cells in vitro
According to Fig. 2-1, after culture with HACP at 12.5-400 μg/mL for 48 h, all the
4T1 cell survival rates were greater than 90%. According to U.S. National Cancer Institute
(NCI), plant extract with an IC50 value less than 20 μg/mL is considered to be cytotoxic
(Vijayarathna & Sasidharan, 2012). Thus, HACP could be regarded as non-cytotoxic.
2.3.3. HACP does not show any acute toxicity in vivo
Before the in vivo anti-tumor assay was carried out, a daily oral toxicity study was
conducted using 1000 mg/kg of HACP treatment for 15 days. During this period, the mice
did not show any abnormal behavior or side effects associated with toxicity. Thus, three
treatment doses, 100 mg/kg, 200 mg/kg, and 300 mg/kg of HACP were selected for
determination of the inhibition effect on 4T1 tumor growth.
2.3.4. HACP inhibited tumor growth in 4T1 cell-bearing mice
As shown in Fig. 2-2A, at the beginning of the experiment, the tumor volume
remained almost the same in each group. From day 12 on, a rapid development of tumor
size in the control group was noticed, and the maximum tumor volume (791.4 ± 76.0 mm3)
was detected in the mice of the tumor control group at the end of experiment. In contrast,
almost 48.07 ± 5.71%, 55.31 ± 4.18% and 62.97 ± 5.42% of inhibition in tumor
progression were recorded for the 100 mg/kg, 200 mg/kg, and 300 mg/kg of HACP treated
groups, respectively. The HACP application not only decreased the tumor volume but also
reduced the tumor weight obviously (Fig. 2-2B). As shown, 100 mg/kg, 200 mg/kg and
300 mg/kg of HACP treatment inhibited the tumor weight by 34.58 ± 10.20%, 57.80 ±
8.65%, and 67.71 ± 5.80%, respectively. No significant change in the mice body weight
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was observed during the treatment period (Fig. 2-2D), indicating the nontoxic effect of
HACP during the 15-day oral administration.
2.3.5. HACP inhibited 4T1 mammary metastasis to lung
Due to the high metastatic ability, 4T1 tumor can easily transfer to the lung, liver, and
bone (Tao et al., 2008). Fig. 2-3 shows the representative histological sections of lungs
from the control and 300 mg/kg HACP treated groups. As indicated by the arrows, the
tumor area in the lungs of the tumor control group were approximately 13.74%. By
contrast, 300 mg/kg of HACP treatment was found to decrease the tumor area to 2.45% of
the total lung area. This result suggests that HACP is effective in decreasing tumor
metastasis to the lung.
2.3.6. HACP induced apoptosis and angiogenesis reduction in tumors
The architecture and morphology of the tumor cells were analyzed by H&E staining.
As shown in Fig. 2-4, the control group showed the normal cellular morphology of 4T1
cell line. However, the HACP treated groups reflected the characteristic features of
apoptosis, cell shrinkage and nuclear chromatin condensation. The angiogenesis expression
of tumor tissues was analyzed by CD34 immunochemistry staining. The staining intensity
of CD34 was significantly reduced in the HACP treated groups. These observations are
consistent with the reduced tumor size and weight in the HACP treatment groups in
comparison to the tumor control group.
2.3.7. HACP increased the immune organ indices, as well as CD4+/CD8+ ratios in
spleen lymphocyte
As shown in Table 2-1, after consecutive administration for 15 days, the spleen and
thymus indices in the HACP treated mice increased obviously compared with the mice in
the tumor control group, indicating an elevated immune response in the HACP treated 4T1
tumor-bearing mice. As is well known, CD4+ and CD8+ are T helper (Th) and T cytotoxic
(Tc) lymphocytes, respectively. A high ratio of CD4+/CD8+ in favor of tumor suppression
has been proven by a previous study (Shen et al., 2013). The results from flow cytometric
analysis demonstrated that the ratio of CD4+/CD8+ in the spleen of tumor control mice was
significant lower (p < 0.05) than those in the HACP treated groups, in support of the fact
that HACP possesses the tumor suppression effect on 4T1 tumor-bearing mice, which is
probably attributed to the lymphocyte activation strategies.
2.3.8. HACP regulated the antioxidant enzymes and cytokines production in serum
of tumor-bearing mice
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In this work, the cytokine levels of TNF-α, IL-6, IFN-γ and IL-1β in the mice serum
were identified. Fig. 2-5A shows that treatment with HACP enhanced TNF-α production in
a dose-dependent manner with the highest level (452.7 ± 85.79 pg/mL) achieved at 300
mg/kg group, which was significantly higher than the tumor control group (102.86 ± 48.46
pg/mL). A similar result was also obtained in IL-1β and IFN-γ generation. As shown in
Figs. 2-5B and 2-5C, 300 mg/kg of HACP treatment increased the production of IL-1β and
IFN-γ by 4.86 and 1.55-fold compared to the tumor control group. In contrast, IL-6
production was noticed to decrease from 235.71 ± 25.74 pg/mL to 91.88 ± 5.17 pg/mL
after 300 mg/kg HACP treatment (Fig. 2-5D). These findings suggest that HACP treatment
exhibited immunomodulatory effects on 4T1 tumor-bearing mice by up-regulating the
TNF-α, IFN-γ, and IL-1β levels and down-regulating the IL-6 production.
The serum levels of CAT, SOD and MDA were also measured in the present study.
The results from Fig. 2-6 show that HACP treatment obviously reduced MDA generation
in the mice serum compared with the tumor control group. In particular, the 300 mg/kg
HACP treatment maintained similar MDA level as the basal condition. In addition, HACP
administration improved the activities of CAT and SOD in the serum of 4T1 tumor-bearing
mice compared with the control group (p < 0.05); however, a dose-dependent effect was
not observed.
2.3.9. Effect of HACP on splenocytes proliferation and NK cell activity
NK cell activity assays are usually used to reflect the body’s in vitro cellular immune
response (Zhang et al., 2005). In this study, HACP was found to significantly enhance the
killing activity of NK cells in the 4T1 tumor-bearing mice (Fig. 2-7). For the 300 mg/kg
HACP treated group, an NK cell activity of 50.17 ± 5.28% was achieved, which is
significantly higher than the tumor control group (25.12 ± 4.72%).
The stimulatory effect of HACP on mouse splenocyte proliferation is shown in Fig.
2-8. Compared to the normal and tumor control groups, HACP treatment at 200 mg/kg or
300 mg/kg significantly promoted splenocyte proliferation. This observation implies that
the increases mouse spleen growth by HACP is probably attributed to the stimulation
effect on splenocyte proliferation.
2.4. Discussion
In the present study, the in vivo immunomodulatory effect of HACP was first
investigated using a 4T1 tumor-bearing BALB/c mouse model. The results suggested that
after 15 days’ administration, HACP was demonstrated to be effective in decreasing the
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tumor growth and lung metastasis. Since HACP did not show any cytotoxic effect on 4T1
cells in vitro (Fig. 2-1), it could be concluded that the in vivo tumor suppression effect was
not brought about by its cytotoxic effect. According to previous works (Cho & Leung 2007;
Schepetkin & Quinn 2006; Wang et al., 2015), many polysaccharides extract from
traditional plants possess anticancer activities in an indirect manner by regulating the host
immune response. For this reason, we further investigated the effects of HACP on
immunity in 4T1 tumor-bearing mice to analyze the underlying antitumor mechanisms.
As the most important immune organs, the spleen and thymus directly participate in
tumor suppression and antitumor cytokine generation (Wang et al., 2015; Zhang et al.,
2004). Generally, a higher organ index indicates a stronger immune capability (Huang et
al., 2016; Zhu et al., 2016). According to Table 2-1, with a spleen index of 28.96 ± 0.45
mg/g in the 300 mg/kg HACP treatment group (TC group, 15.09 ± 1.60 mg/g), HACP was
found to significantly elevate spleen organ growth, which may result from its potent
splenocytes proliferation ability (Fig. 2-8). The spleen indices for the 4T1 tumor-bearing
mice were significantly (p < 0.05) higher compared to the normal group, which is in
agreement with previous reports that, to some extent, found the spleen weights of mice
with breast cancer to be much higher than those in normal mice (Aragon et al., 2014;
Razali et al., 2016). The CD8+ T cell can specifically and directly kill cancer cells, thus
exhibiting cytotoxic effects. On the other hand, CD4+ cells, namely, helper T cells, always
help activate other immune cells, including macrophages and NK cells, by releasing
cytokines (Zhu et al., 2016). The present results suggest that HACP could significantly (p
< 0.05) increase the percentage of CD4+ and CD8+ T cells, and up-regulate the ratio of
CD4+/CD8+ cells, indicating their participation in antitumor activity in vivo.
Since cytokines play a vital role in the regulation of the host immune response, the
identification of cytokine levels is often used as a parameter to evaluate the
immunomodulatory effect (Razali et al., 2016). Numerous studies have demonstrated that
TNF-α plays a pivotal role in the regulation of immunoregulatory mediator expression and
antitumor activity (Baugh & Bucala 2001; Zhang et al., 2017). In the present study, after
15 days’ treatment, an almost 4-fold increase in TNF-α production was detected in the 300
mg/kg HACP treatment group compared with the tumor control group. IFN-γ and IL-1β
have many functions and are very important in the host defense against the tumor (Razali
et al., 2016; Zhang et al., 2013). The application of HACP was found to efficiently
stimulate mouse serum IFN-γ and Il-1β release in this study, suggesting that HACP could
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activate the immune response of 4T1 tumor-bearing mice through the up-regulation of
TNF-α, IFN-γ and IL-1β. Moreover, IL-6, as a pro-angiogenic factor, is essential for breast
tumor growth and metastasis (Aragon et al., 2014). In the present study, the tumor control
group with the highest tumor size and lung metastasis status demonstrated a significant
increase in the IL-6 production, while the HACP treated mice were found to maintain
similar IL-6 levels as their normal conditions (Fig. 2-5). This result is consistent with
Zhang et al. (2017), who also observed a reduced release of IL-6 after administration of
Royal Jelly for 42 days using a 4T1-tumor bearing mice model. It is believed that the lower
level of IL-6 induced by HACP contributes to the suppression of tumor progression.
It is well known that excessive oxidative stress is an underlying cause of cancer (Telo
et al., 2017). Antioxidant enzymes are essential in protecting the host against oxidative
stress (Huang et al., 2016; Zeng et al., 2017), among which CAT is a very important
enzyme that can detoxify hydrogen peroxide into water, and SOD plays a major role in
host defense against oxygen toxicity (Murk et al., 2002). Moreover, MDA is one of the
most important end-products of lipid peroxidation, and its level in the serum signals the
degree of lipid peroxidation. In the present study, HACP administration significantly
improved the activities of CAT and SOD, and decreased MDA levels in the serum of 4T1
tumor-bearing mice (Fig. 2-6), suggesting that HACP exhibits antioxidant effects, which
may partially contribute to its antitumor effects.
2.5. Summary
All the above findings suggest that HACP could enhance the immune response in 4T1
tumor-bearing mice. The small size and reduced vascularization in the tumors and
decreased lung metastasis in the mice clearly reflect the beneficial effects of the immune
response regulated by HACP treatment. Thus, HACP could be developed as a new product
for breast cancer treatment with immunomodulatory activity in the future.
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Table 2- 1 Effects of HACP on immune organ indices, and T cell subsets in the spleen of
tumor bearing mice.
Group Spleen indices
(mg/g)
Thymus indices
(mg/g)
CD4+ (%) CD8+ (%) CD4+/CD8+
NC 7.54 ± 2.72d 1.68 ± 0.29c 11.33 ± 1.48c 4.70 ± 1.21a 2.46 ± 0.14a
TC 15.09 ± 1.60c 1.69 ± 0.27c 8.59 ± 0.92c 4.18 ± 0.22b 2.05 ± 0.18b
100 mg/kg 20.66 ± 3.32b 2.42 ± 0.33 b 13.59 ± 3.62b 6.44 ± 1.56a 2.10 ± 0.12b
200 mg/kg 19.11 ± 4.70b 2.59 ± 0.19b 12.48 ± 1.16b 5.03 ± 0.46a 2.48 ± 0.03a
300 mg/kg 28.96 ± 0.45a 2.97 ± 0.21a 17.35 ± 3.04a 6.72 ± 1.84a 2.64 ± 0.31a
Results are represented as the mean ± SD (n = 6). NC: normal control, TC: tumor control.
a–dValues in the same column with different superscript letters indicate a significant
difference (p < 0.05).
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Figure 2- 1 In vitro cytotoxic effect of HACP on 4T1 breast tumor cells
Cells were cultured with HACP (12.5-400 μg/mL) for 48 h. The results are represented as
the mean ± SD (n = 6). Bar values with the same letter (a) indicate no significant difference
from the control group (p > 0.071, for all HACP treated groups).
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Figure 2- 2 Inhibition effects of HACP on 4T1 tumor growth
(A) Tumor volumes in 4T1 tumor-bearing mice, (B) Tumor weight of 4T1 tumor-bearing
mice, (C) Tumors sampled from experiment groups, and (D) Changes in body weight of
the mice. The results are represented as the mean ± SD (n = 6). NC: normal control, TC:
tumor control. Bar values with different letters (a–c) indicate a significant difference (p <
0.05).
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Figure 2- 3 Inhibition effects of HACP on 4T1 tumor metastasis to lung
(A) H&E staining of lung organs of 4T1 tumor-bearing mice, (B) Tumor burden of the
lungs in 4T1 tumor-bearing mice. The results are represented as the mean ± SD (n = 5).
Bar values with different letters (a, b) indicate a significant difference (p < 0.05).
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Figure 2- 4 H&E staining and CD34 immunochemistry of tumor tissues from 4T1
tumor-bearing mice
Tumor control 100 mg/kg HACP 200 mg/kg HACP 300 mg/kg HACP
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Figure 2- 5 Cytokine production in mice serum
(A) TNF-α production, (B) IL-1β production, (C) IFN-γ levels, and (D) IL-6 production in
mouse serum. The results are represented as the mean ± SD (n = 6). NC: normal control,
TC: tumor control. Bar values with the different letters (a–e) indicate a significant
difference (p < 0.05).
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Figure 2- 6 Antioxidant enzyme levels in the serum of 4T1 tumor-bearing mice
(A) MDA levels in mice serum, (B) SOD activity, and (C) CAT activity in the serum of
4T1 tumor-bearing mice. The results are represented as the mean ± SD (n = 6). NC: normal
control, TC: tumor control. Bar values with the different letters (a–d) indicate a significant
difference (p < 0.05).
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Figure 2- 7 Effect of HACP on the NK cell activity of 4T1 tumor-bearing mice
The results are represented as the mean ± SD (n = 6). NC: normal control, TC: tumor
control. Bar values with different letters (a–c) indicate a significant difference (p < 0.05).
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Figure 2- 8 Effect of HACP on splenocytes proliferation of 4T1 tumor-bearing mice
The results are represented as the mean ± SD (n = 6). NC: normal control, TC: tumor
control. Bar values with the different letters (a–d) indicate a significant difference (p <
0.05).
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Chapter 3 Purification and characterization of polysaccharide fractions
from HACP
3.1. Introduction
Polysaccharide is a high molecular weight polymer, which consist of at least ten
monosaccharide joined by glyosidic linkages (Wang et al., 2016). Because of the
differences in monosaccharide compositions, glyosidic linkages, and degrees of
polymerization, the structure of polysaccharide is far more complicated than protein and
nucleic acid. Furthermore, other factors, such as extraction methods and purification
procedures are evidenced to have significant influence on the physicochemical and
structural properties of polysaccharides.
Generally, polysaccharides are present together with proteins, lipids, and lignin.
However, the impure compounds may influence the biological activities of the
polysaccharides, which may even cause undesirable toxicity (Yu et al., 2018). In other
words, pure polysaccharides could enable the safe, bioactivities, and also enable the
investigation of structure/activity relationship. Thus, further purification of bioactive
polysaccharides from crude extracts, such as ethanol precipitation, ion-exchange
chromatography, and gel filtration are of high importance. Among them, anion exchange
column chromatography is the most commonly applied method in purification of
polysaccharides at present (Shi, 2016). Polysaccharide solution can be concentrated and
preliminarily purified through this method.
In this chapter, three major polysaccharide fractions of HACP was purified stepwise
with DEAE Sepharose Fast Flow and Sephacry S-400 column chromatography,
successfully. And the primary structure features and molecular weight of the obtained
polysaccharide fractions were determined.
3.2. Materials and methods
3.2.1. Chemicals and reagents
DEAE Sepharose Fast Flow and Sephacry S-400 chromatography were obtained from
GE Healthcare Bio-sciences (Uppsala, Sweden). Carbazole and D-Galacturonic acid were
purchased from Wako (Japan). Protein Quantification Kit-Rapid was obtained from
Dojindo Molecular Technologies (Japan). All the reagents used in this study were of
analytical grade.
3.2.2. Purification of HACP
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The HACP was purified sequentially by using DEAE Sepharose Fast Flow
anion-exchange chromatography and Sephacryl S-400 size exclusion chromatography.
Briefly, approximately 300 mg of HACP was dissolved in 10 mL of ultrapure water and
applied to DEAE Sepharose Fast Flow column (450 × 40 mm), followed by eluting
stepwise with ultrapure water, 0.1, 0.3, and 0.5 M NaCl at a flow rate of 3 mL/min. The
elution (6 mL/tube) of each fraction was collected and detected by using the
phenol-sulfuric acid method (DuBois, Gilles, Hamilton, Rebers, & Smith, 1956). Totally
600 mL of wash solution was used for each fraction. Then, the fractions were concentrated
at 50 C by rotary evaporation under reduced pressure, and lyophilized to obtain SPF1,
SPF2, SPF3 and SPF4, respectively. Fraction SPF1, SPF2, SPF3 were further fractionated
with Sephacry S-400 column (450 × 20 mm) eluted with ultrapure water at a flow rate of
0.5 mL/min. The fractions (3 mL/tube) were collected and analysed by the upper way.
Finally, the major fraction named SPF1-1, SPF2-1, and SPF3-1 were then collected, and
lyophilized to powder.
3.2.3. Chemical composition and molecular weight (Mw)
The uronic acid content of polysaccharide fractions were determined by modified
carbazole method according to a previous research (Bitter & Muir, 1962). And the protein
content was determined with the protein quantification kit according to the manufacture
procedure.
The neutral monosaccharaides composition was determined by using high
performance anion exchange chromatography (HPAEC) with pulsed amperometric
detection (PAD). Fraction SPF1-1, SPF2-1, and SPF3-1 (10 mg) were hydrolysed with 4 M
of trifluoroacetic acid (TFA, 4 mL) at 120 C for 4 h in a sealed tube. After cooling to
ambient temperature, the excess TFA was removed, and then the residue was re-dissolved
in 10 mL of ultrapure water, the resultant solution was diluted for 50 times and filtered
through a 0.22 μm filter. The derivatives were then performed on a Dionex HPAEC-PAD
system (Dionex, USA) with an advanced gradient pump and eluent degas module. The
monosaccharide composition was identified as described previously (Cai et al.,, 2016). The
Mw was determined by using a high-performance size elusion chromatography instrument
equipped with multi-angle laser light scattering and refractive index
(HPSEC-MALLS-RID) system according to the method described by Yang et al. (2016)
with some modifications. The HPSEC-MALLS-RID system consists of a pump (e2695,
Waters, USA), a HPSEC columns (TSKgel SuperMultipore PW-M, TOSOH, Japan), a
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MALLS detector (DAWN HELEOSII, Wyatt Technology, Santa Barbara, CA, USA), and
a RI detector (OPtilab T-rex, Wyatt Technology, Santa Barbara, CA, USA). 10 mg of
polysaccharide fraction was dissolved in 1 mL of distilled water and filtered through a 0.22
µm filter. Twenty μL of solution was injected into the HPSEC column and eluted with
distilled water at a flow rate of 0.5 mL/min.
3.2.4. FTIR and UV spectroscopy
The structure features of polysaccharides were analysed by using a Fourier transform
infrared spectrophotometer (FT/IR-300, JASCO, Japan). Samples were ground with
potassium bromide (KBr) powder and pressed into a pellet for FTIR measurement at a
frequency range of 4000-500 cm−1.
For UV spectrum analysis, the aqueous solution of SPF1-1, SPF2-1, and SPF3-1 at
1.0 mg/mL was scanned at the wavelength from 190 to 600 nm on a UV-vis
spectrophotometer (UV-3100PC, SHIMADZU, Japan).
3.2.5. Nuclear magnetic resonance (NMR) analysis
Polysaccharide fractions (7 mg) were dissolved in 0.6 mL D2O in an NMR tube. 1H
NMR analysis was performed on a Bruker AVANCE-600 NMR Spectrometer.
3.2.6. SEM analysis
SEM was used to characterize the micro-structures and surface morphologies of
materials in the fractions. Dried samples of the three purified fractions were fixed on a
specimen holder, coated using ion beam sputtering deposition, and then examined at a 5
KV acceleration voltage in a vacuum specimen chamber. The shape and surface
characteristics were observed, and images were collected using a scanning electron
microscope (JSM6330F, Japan), followed by magnification at 250-500×
3.3. Results and discussion
3.3.1. Purification and separation of HACP
The HACP was separated with a DEAE Sepharose Fast Flow chromatography as
shown in Fig. 3-1A. Result indicates that HACP was mainly composed of four fractions
(SPF1, SPF2, SPF3, and SPF4) which were eluted with the ultrapure water, 0.1 M, 0.3 M,
and 0.5 M NaCl, yielding about 15.3%, 12.7%, 22.3%, and 8.1% of the amount of HACP,
respectively. The fractions SPF1, SPF2, and SPF3 were selected and their further
separation was performed on a Sephacyl S-400 column. Finally, the major fraction SPF1-1,
SPF2-1, and SPF3-1 were collected and lyophilized (Fig. 3-1B-D).
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3.3.2. Monosaccharide composition and molecular weight
The chemical composition and molecular weight of three fractions are shown in Table
3-1. Results indicated that three fractions SPF1-1, SPF2-1 and SPF3-1 are acidic
polysaccharides with uronic acids of 12.70 ± 1.80%, 26.92 ± 2.81%, and 58.77 ± 1.64%,
respectively. The main sugar component of SPF1-1 is glucose. The main neutral sugars of
SPF2-1 are arabinose and glucose, and for SPF3-1 are rhamnose (Rha), arabinose (Ara)
and galactose (Gal). The protein content of SPF1-1, SPF2-1, and SPF3-1 were low (1.79%,
1.55% and 1.09%, respectively). And the molecular weight (Mw) of SPF1-1, SPF2-1, and
SPF3-1 were determined to be 279 kDa, 15.69 kDa, and 13.36 kDa.
3.3.3. UV and FT-IR spectra analysis
The UV spectra of polysaccharide fractions are shown in Fig.3-2. In accordance with
protein content in Table 3-1, fractions SPF1-1, SPF2-1, and SPF3-1 were not be detected
significant absorption peaks in the wavelength of 280 nm and 260 nm by an ultraviolet
spectrophotometer, which indicates that protein and nucleic acid have been reduced to the
lowest amount.
The structure of fraction SPFs were identified by FT-IR spectra. As shown in Fig. 3-3,
SPF1-1, SPF2-1, and SPF3-1 displayed absorption peaks typical of polysaccharides in the
range of 4000-500 cm-1. All polysaccharides displayed a broad stretching intense
characteristic peak between 3440 and 3422 cm-1, which was the stretching vibration peak
of O-H in the sugar molecule. The weak peaks towards 2938-2923 cm-1 was belonged to
the C-H bond of CH3 or CH2 (Hu et al., 2015). The absorption occurring at around
1639-1629 cm-1 and 1410-1420 cm-1 can be assigned to carboxylate ion stretching band
(COO-), reflecting the existence of uronic acids (Gnanasambanda 2000; Zhang et al., 2013),
this result was consistent with the uronic content identified in Table 3-1. The additional
peaks at 1737 cm-1 and 1248 cm-1 in SPF3-1 can be attributed to ester carbonyl (C=O)
group and C=O dilatation vibration, which is one of the typical characteristic s of pectin
(Wang, et al., 2014). Besides, the peaks at 1024-1035 cm-1 and 1079cm-1 were attributed to
the arabinofuranose units and galactopyranose from of the backbone of the arabinogalactan.
Moreover, the absorption peak at 625-522 cm-1 signals that polysaccharide fractions
contain α-configurations (Zhao et al., 2017).
3.3.4. NMR analysis
The structure feature of three SPFs were further analysed by the NMR spectra
(Fig.3-4) and the signals in 1H NMR spectra were identified through referring previous
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literatures (Huang et al., 2017; Klosterhoff et al., 2018; Shen et al., 2017; Wei et al., 2017;
Zhang et al., 2017). The region ranging from δ 3.0-5.5 ppm which were the typical of
polysaccharide. The significant signals at δ 5.35, 3.92, 3.89, 3.82, and 3.59 ppm in SPF1-1
could be attributed to →4)- α-Galp-(1→ , →6)- β-Galp-(1→, →4)- α-GalpA, →1)-
α-GalpA-(4→, and α-Glc(1→1, respectively (Fig.3-4A). The peak at δ 1.23 ppm in SPF2-1
was assigned to the –CH3 (C6) of rhamnose, demonstrating the existence of rhamnose. And
the anomeric proton at δ 3.58, 3.66, 3.87, 3.99 and 5.29 ppm were attributed to the →
1)-α-GalpA-(1→, → 6)-β-Galp-(1→, →1)-α-Rhap-(2, 4→, and → 4)-α-Galp-(1→,
respectively (Fig.3-4B). The anomeric protons at δ 5.15, 5.04, 4.97, and 4.63 ppm in
SPF3-1 corresponded with H-1 of anomeric residues α-Araf-(1→, →5)-α-Araf-(1→, →
2,4)-α-Rhap-(1 → , and α-Rhap-(1→ residues, respectively. And at δ 1.31 ppm, it was
assigned to the H-6 of α-L-Rhap.
3.3.5. SEM analysis
The polysaccharides isolated in the present study had different textures and surface
properties, as revealed using SEM (Fig.3-5). The result show that SPF1-1 was thin porous
lamellar structure, SPF2-1 was collective massive structure, and SPF3-1 was fine
powdered structure.
3.4. Discussion
In general, the techniques used to extract, purify and separate plant polysaccharides
can affect their characteristics (Yu et al., 2017). In this study, three major polysaccharide
fractions SPF1-1, SPF2-1, and SPF3-1 were separated and purified from HACP by DEAE
Sepharose Fast Flow and Sephacryl S-400 chromatography, yielding 7.4%, 6.9% and 9.8%
of the total amount of HACP, respectively. Monosaccharide composition identification
indicated that these three isolated fractions are typical pectic polysaccharides which
contain similar types of monosaccharide, while they are different in their contents. The size
of molecular weight is another critical structural property of polysaccharides, which largely
affect its physical and chemical properties. In the present study, the molecular weight of
SPF1-1, SPF2-1, and SPF3-1 are 279, 15.69, and 13.36 kD, respectively.
In order to investigate the structure of SPFs fractions, their FT-IR spectrums were
recorded from 4000 to 500 m-1 using films prepared by the dried polysaccharides and KBr
pellets. Results (Fig. 3B) reflect that three polysaccharide fractions have the typical
characteristic absorption bands of polysaccharides at 4000-500 cm-1. For instance, all the
fractions display a broad stretching peak at around 3440-3422 cm-1 for the hydroxyl group,
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a weak peak at 2938-2923 cm-1 reflects the characteristic absorption of C-H stretching
vibration (Hu et al., 2015; Liu et al., 2016). Besides, the absorptions at 1000-1200 cm-1
attributed to the ring vibrations overlapped with stretching vibrations of C-OH side groups
and the C-O-C glyosidic vibration, suggested the presence of pyranose form of sugars. The
difference between SPF1-1, SPF2-1, and SPF3-1 was that SPF3-1 had additional peaks at
1737 cm-1 and 1248 cm-1, which were characteristic of ester group and acetyl group,
indicated that the GalA units in polysaccharide SPF3-1 was esterified. No significant
absorption peak was found at 260-280nm in UV spectrum, implying the absence of protein
(Yu et al., 2017). This observation also demonstrates the effectiveness of the fractionation
and purification procedures in this study.
Furthermore, NMR was applied to characterize the main structure feature of SPFs.
The signals observed in the 1H spectra of each fraction were assigned based on published
values. NMR spectroscopic analysis demonstrated that all of the fractions contained
heteropolysaccharides. The 1H signal at δ 4.70 ppm is due to D2H. The chemical shifts
ranging from δ 3.5-4.5 ppm were attributed to C-2-C-6 protons. SPF1-1 showed the
presence of three major anomeric proton signals at δ 5.35, 3.89, and 3.80 ppm, which were
assigned as the proton at C-1 for the following structures: → 4)-α-Galp-(1 → , →
4)-α-GalpA, →1)- α-GalpA-(4→. The peaks at δ 1.23 ppm in SPF2-1 and SPF3-1 was
assigned to the –CH3 (C6) of rhamnose, demonstrating the existence of rhamnose. The 1H
signals at δ 5.14/4.98 ppm from SPF3-1 proved that the α-GalpA was partly methyl
esterified (Fig. 3-4C). This was consistent with the FT-IR result in Fig. 3-3C.
3.5. Summary
In this chapter, three major fractions were purified from HACP. SPF1-1, SPF2-1, and
SPF3-1 were acidic polysaccharides and differed in molecular weight, monosaccharide
composition, and ultrastructure. This study will expand the knowledge of the structural
features of polysaccharides from H. angustifolia. Further, it can help determine the
relationship between the structure of the obtained substances and their useful properties
during studies of their physiological and biological activity.
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Figure 3- 1 Purification and characterization of polysaccharide fractions from HACP
(A) Elution profiles of HACP on the chromatography column DEAE Sepharose Fast Flow;
(B) Elution curve of fraction SPF1-1 on size-exclusion chromatography Sephacry S-400;
(C) Elution curve of fraction SPF2-1 on Sephacry S-400; and (D) Elution curve of fraction
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SPF3-1 on Sephacry S-400.
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Figure 3- 2 UV spectrum of polysaccharide fractions: (A) SPF1-1; (B) SPF2-1; (C) SPF3-1
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Figure 3- 3 FTIR spectrum of polysaccharide fractions
(A) FTIR spectrum of fraction SPF1-1; (B) FTIR spectrum of fraction SPF2-1; and (C)
FTIR spectrum of fraction SPF3-1.
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Figure 3- 4 1H NMR spectrum of polysaccharide fractions
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SPF1-1 SPF2-1 SPF3-1
Figure 3- 5 SEM analysis of polysaccharide fractions SPF1-1, SPF2-1, and SPF3-1
250×
500×
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Chapter 4 In vitro antioxidant and immunomodulatory effects of
polysaccharide fractions
4.1. Introduction
Oxidative stress is commonly defined as an imbalance between the production of
reactive oxygen species and antioxidant defense. Many disease, such as asthma,
inflammation, and diabetes, are thought to be linked to oxidative stress (Atoui et al., 2005;
Metcalfe & Alonso-Alvarez, 2010). Antioxidants are defined as the substances which are
involved in the prevention of excessive reactive species oxidation at low concentrations
(Sarangarajan et al., 2017). Natural antioxidants are reported as a kind of effective free
radical scavenger which playing a critical role in protecting body against oxidative stress.
Methods used for measuring antioxidants activity of those substances have advanced
remarkably during the last few decades. To date, carious chemical assays coupled with
highly sensitive and automated detection technologies are employed for evaluation of
antioxidant activity through particular mechanisms, for example, scavenging activity
against certain types of free radicals, reducing power, and metal chelation.
Immunomodulation is regarded as one of the important body’s defense against
pathogens, inflammatory diseases, and cancer. Our immune system contains several kinds
of immune cells. Among them, macrophage cell is important target for studying cellular
immunity and molecular immunology, and it is an important cellular bridge between innate
and adaptive immunity. In recent years, polysaccharide from natural sources have attracted
extensive attention due to their structural diversity, low toxicity and strong antioxidant and
immunomodulatory activities. Therefore, discovery and evaluation of polysaccharides with
antioxidant and immunomodulatory properties has emerged as one of the important
research fields in chemistry and biology and medicine.
4.2. Materials and methods
4.2.1. Chemicals and reagents
Dulbecco’s modified eagle medium (DMEM), streptomycin, penicillin and fetal
bovine serum (FBS) were obtained from GIBCO (Grand Island, NY, USA). 2, 2'-Azino-bis
(3-ethylbenzothiazoline-6sulfonic acid) (ABTS) and 2, 2-diphenyl-1-picry-hydrazyl radical
(DPPH), Griess reagent, lipopolysaccharide (LPS), 3-(4, 5-Dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT), and Red blood cell lysis buffer were purchased
from Sigma Aldrich, Inc. (Saint Louis, MO, USA). Mouse TNF-α, and IL-6 ELISA Kits
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were purchased from eBioscience (San Diego, CA, USA). All the reagents used in this
study were of analytical grade.
4.2.2. Antioxidant activity assays
(1) DPPH radical scavenging activity
The DPPH radical scavenging activity of root or leaf extracts were assessed according
to a literature with some modifications (Zhang et al., 2015). 2 mL different concentrations
(62.5-1000 μg/mL) of the test samples were mixed with 2 mL DPPH (2 mM); the mixture
was shaken vigorously and then incubated for 30 min at room temperature at dark place.
The OD value was measured at 517 nm using a spectrophotometer. Decrease in absorbance
of the DPPH solution indicated an increase of the DPPH radical-scavenging activity. In
this study, ascorbic acid was used as the positive control and DPPH radical-scavenging
activity was assessed by the following equation:
DPPH radical-scavenging activity (%) = (1 –A1 /A0) × 100%.
Where, A1 and A0 were the absorbance of the sample (tested fractions) and control,
respectively.
(2) Hydroxyl radical scavenging activity
The hydroxyl radical scavenging activity was determined according to a literature
procedure (Smirnoff & Cumbes, 1989) with some modiﬁcations. Different concentration
(62.5-1000 μg/mL) of SPFs (100 µL) was mixed with 50 µL of FeSO4 (1.5 mM), 35 µL of
H2O2 (60 mM), and 15 µL of sodium salicylate (20 mM). The mixture was mixed
thoroughly and incubated at room temperature for 60 min. In this study, Trolox was used
as the positive control. The absorbance was measured at 562 nm.
Hydroxyl radical scavenging activity was expressed as a rate (%) and calculated as:
% scavenging of OH• = [1-(A1–A2/A0] × 100%, where, A1 was the absorbance of
the sample or ascorbic acid, and A2 was the absorbance of the reagent blank without
sodium salicylate, whereas A0 was the absorbance of the solvent control, respectively.
(3) ABTS radical scavenging activity
The ABTS radical scavenging activity was measured according to a literature
procedure (Debnath et al., 2011) with some modifications. 25 mL of ABTS •+ solution
(7mM) was mixed with K2S2O8 solution (140 mM) and stored the mixture in the dark at
room temperature for 15-16 h before use. The ABTS • + solution was diluted with a
phosphate buffered saline (PBS, pH = 7.4) to obtain the absorbance to within 0.70 ± 0.02 at
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734 nm. Then 0.15 mL of various concentrations (125-2000 μg/mL) of the samples were
mixed with 2.85 mL of ABTS•+, and the absorbance was measured at 734 nm after
incubation at room temperature for 10 min.
The scavenging activity of ABTS free radical was calculated by the following
equation:
ABTS scavenging activity (%) = (C - D) - (A – B) / (C - D) × 100
Where, A = absorbance of ABTS solution + sample/standard, B = absorbance of PBS
+ sample/standard, C = absorbance of ABTS solution + distilled water, and D = PBS +
distilled water.
(4) Reducing power
The reducing power of tested samples was measured according to a literature
procedure (Li et al., 2015). Different concentrations (250-4000 μg/mL) of sample solution
(1 mL) was mixed with 1 mL of phosphate buffer (200 mM, pH 6.6), and 1mL of 1%
potassium hexacyanoferrate [K3Fe (CN)6], the mixture was then incubated for 20 min
using a water bath at 50°C. After incubation, 1mL of 10% trichloroacetic acid (TCA, w/v)
was added, and then centrifuged at 1500 rpm/min for 10 min. The supernatant (2 mL) was
mixed with 2 mL of distilled water and 0.4 mL of 0.1% ferric chloride (FeCl3). Finally, the
absorbance was measured at 700 nm using a spectrophotometer. A higher absorbance
means a higher reducing power activity. In this study, Trolox was used as the positive
control.
(5) Ferrous ion chelating activity
The ferrous ion chelating ability of samples was investigated as reported previously
(Kalın, Gülçin, & Gören, 2015) with modifications. Samples (50 μL) in various
concentrations were mixed with FeSO4 (100 μL, 0.13 mM) and the reaction was performed
by adding 50 μL ferrozine (2.0 mM) to the mixture. The mixture was left standing for 10
min at 25°C and then the absorbance at 562 nm was detected. Ethylene diamine tetraacetic
acid disodium salt (EDTA-2Na) was used as the positive control.
The ferrous ion chelating activity was estimated by the following equation:
Fe2+ chelating activity (%) = [1 - A1 - A2 / A0] × 100
where deionized water was used as the blank control. A0 was the value of the
absorbance, A1 was the absorbance of the reaction system, containing both test sample and
reaction solution, and A2 was the absorbance of the test sample only with deionized water
instead of reaction solution.
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(6) Superoxide anion radical scavenging activity
Superoxide anion radical scavenging activity of polysaccharide fractions was based
on the method described by (Chidewe et al., 2016). 1 mL of nitroblue tetrazolium (NBT)
solution (156 μM NBT in 100 mM phosphate buffer, pH 7.4) was mixed with 1 mL of
NADH solution (468 μM NBT in 100 mM phosphate buffer, pH 7.4) and 1 mL of
polysaccharide solutions (31.25-1000 μg/mL). The reaction then started by adding 100 μL
of phenazine methosulphate (PMS) solution (60 μM PMS in 100 mM phosphate buffer, pH
7.4) to the mixture. The reaction mixture was incubated at 25°C for 5 min and the
absorbance at 560 nm was measured against blank sample. Decreased absorbance of the
reaction mixture indicated increased superoxide anion scavenging activity. The percentage
inhibition of superoxide anion generation was calculated using the formula:
% inhibition of superoxide anion = [(A0 - A1) / A0] × 100.
Where A0 is the absorbance of the control, and A1 is the absorbance of the sample or
standard.
4.2.3. Cell line and culture
Human fibrosacoma cell line HT1080 were obtained from Riken Cell Bank (Tsukuba,
Japan), and cultured with DMEM supplemented with 10% FBS, penicillin (100 U/mL) and
streptomycin (100 µg/mL) at 37°C in an incubator with 5% CO2 atmosphere.
4.2.4. Cytotoxicity of SPF3-1
The effects of SPF3-1 on HT1080 cell viability were identified by using MTT assay
according to Li et al. (2016). Cells (5000 cell/well) were treated with/without virous
concentrations of polysaccharide fractions (6.25-400 µg/mL) for 24 h. The optical density
at 450 nm was measured by using a Model 550 microplate reader (BIO-RED, Tokyo,
Japan).
4.2.5. In vitro immunomodulatory activities
(1) Macrophages proliferation activity
Briefly, RAW264.7 cells were suspended in DMEM and adjusted to a concentration
of 5 × 104 cells/mL. One hundred microliters cell solutions were loaded onto 96-well
culture plates and cultivated overnight, and then treated with polysaccharide samples at
different concentrations (6.25-100 µg/mL) for 24 h. Cells treated with DMEM medium
only was used as blank control. After incubation, cell viability was determined by CCK-8
assay.
(2) Phagocytic activity determination
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The phagocytic uptake ability of macrophages was measured according to the method
described previously (Li et al., 2016) with some modifications. Macrophages were
pre-incubated in 96-well plates for 12 h and then treated without/with polysaccharide
fractions at various doses (6.25-100 µg/ml) for 24 h, followed by addition of 100 µL of
neutral red (0.7%, w/v) and cultivation at 37°C for 1 h. Finally, the medium was discarded,
and the cells were washed with cold PBS for three times. Afterwards, cell lysis buffer (1%
glacial acetic acid: ethanol = 1:1, 100 µL/well) was added and the cells were incubated at
room temperature (25  2°C) for another 1 h, and then the optical density at 540 nm was
measured by using a microplate reader.
(3) Measurement of the nitric oxide (NO) production
RAW 264.7 cells (1 × 105 cells/well) were cultured in 48-well plates and stimulated
with or without various doses of samples (6.25-100 µg/mL). LPS (10 µg/mL) was used as
the positive control. After 24 h of incubation, the culture supernatant was collected, and
NO level was measured by using Griess reagent assay (Li et al., 2017).
(4) Protective activity on doxorubicin (DOX)-induced damage
RAW 264.7 cells were seeded in a 96-well plate at 5 × 103 cells/well. After 24 h of
adherence, cells were treated with DOX (0.5 µmol/L, final concentration) in the absence or
presence of various concentrations (6.25-100 µg/mL) of SPFs for 24 h. Cell viability was
determined using CCK-8 method.
(5) Analysis cytokines release in culture medium
RAW 264.7 cells were treated with SPF3-1 (6.25-100 µg/mL) for 24 h. The cytokines
TNF-α, and IL-6 released in culture supernatant were determined by the mouse TNF-α, and
IL-6 ELISA Ready-SET-Go reagent sets (eBioscience, San Diego, USA) ELISA Kits
according to the instruction of manufacturers. Brieﬂy, an ELISA plate was coated with the
capture antibody overnight at 4°C and then filled successively with block solution for 1 h.
Next, assay dilution (blank), standards, and samples (culture supernatant) were incubated
for 2 h, and this was followed by incubation with antibody detection for 1 h at room
temperature. Finally, substrate and stop solution were added to each well, and the optical
density was measured at 450 nm. The cells treated with LPS (10 µg/mL) were used as the
positive control, and those cultured in DMEM medium in the absence of SPF3-1 and LPS
were used as the negative control.
(6) Macrophage-mediated cytotoxicity
The macrophage-mediated cytotoxicity was identified according to Mao et al. (2015)
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and Wang et al. (2016) with some modifications. RAW264.7 cells were plated in 24-well
plate (2 × 105 cells/well) for 24 h of adherence, followed by LPS (10 µg/mL) or various
concentrations of SPF3-1 treatment. The cells without any treatment was used as the
control group. After 24 h, the supernatant and adherent cells were collected individually.
Then, the supernatants were added to a 96-well plate containing adherent HT1080 cells
(target cell: 4 × 103 cells/well) and cultured for 48 h. HT1080 cell viability was identified
by using MTT assay. Simultaneously, 100 µL of the above SPF3-1 pre-activated
macrophage cells (effector cells, 2 × 105 cells/mL) were co-incubated with 100 µL of
adherent HT1080 cells (target cells, 2 × 104 cells/mL) for 48 h. The HT1080 cells
co-incubated with macrophage cells which without SPF3-1 treatment was used as negative
control group, and cells cultured with LPS pre-activated macrophages was used as positive
control. The cell viability was calculated by using the following equation: HT1080 cell
activity (%) = 100 × (ODT - (ODS - ODE)) / ODT, where ODT means the optical density of
target cells control, ODS is the optical density of tested sample, and ODE is the optical
density of the effector cells control.
(7) Spleen lymphocytes proliferation and cytokines generation assay
Spleen lymphocytes were isolated from BALB/c mice as described in 2.2.9, chapter 2.
Lymphocytes were seeded into 96-well plates at a density of 5 × 105 cells per well. SPF3-1
was added at the indicated concentrations, ranging from 6.25 to 100 μg/mL, and incubated
for 48 h. Cell viability was identified by using CCK-8 kit.
In order to identify the cytokines produced by SPF3-1 treated lymphocytes, cells were
seeded into 96-well plates at a density of 1 × 106 cells per well. SPF3-1 was added at
various concentrations ranging from 6.25 to 100 μg/mL and incubated for 24 h. Then, the
culture supernatants were collected, and cytokine quantification of IFN-γ and IL-6 was
performed using ELISA kits according to the manufacturer’s instructions.
4.2.6. Statistical analysis
All the data were expressed as means ± standard deviation (SD), and the results used
in this work were from at least three independent experiments performed in triplicate. In
addition, the statistics were analysed using one-way analysis of variance (ANOVA) with
the Duncan’s multiple-range test. *p < 0.05, **p < 0.01, and ***p < 0.001 were considered
as statistically significant.
4.3. Results and discussion
4.3.1. In vitro antioxidant activities
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(1) Scavenging ability on DPPH radicals
The DPPH radical scavenging assay is a common method that has been widely used
to determine the free radical scavenging activity of natural antioxidant. DPPH radical is a
stable free radical and has purple color in ethanol solution. Once an antioxidant was added
to this system, DPPH radical could easily accept hydrogen atom donated by antioxidant to
become a stable molecule which result in a purple colour erosion. The decrease of the color
absorption indicates a higher DPPH radical scavenging ability. In the present research, the
DPPH radical scavenging activity of SPF1-1, SPF2-1, and SPF3-1 are shown in Fig.4-1A.
The scavenging ability against DPPH radical of SPF3-1 increased significantly with the
increasing concentration. When the concentration approached to 1000 μg/mL, the
scavenging rate of SPF3-1 was 74.59%, obviously higher than fractions 1-1 and 2-1
(24.02% and 33.04%, respectively).
(2) Hydroxyl radical scavenging assay
The hydroxyl radical is the most active among oxygen radicals and induces severe
oxidative injury to the adjacent bio-molecular. Hence, removing hydroxyl radical is
important for the protection of living systems. As shown in Fig. 4-1B, the scavenging
activity of SPFs on hydroxyl radical improved with the increase of concentration which
exhibits a dose dependent manner. SPF3-1 has showed highest inhibition activity against
hydroxyl radical, followed by SPF2-1 and SPF1-1.
(3) ABTS radical scavenging ability
The ABTS radical scavenging assay is extensively applied to measure the total
antioxidant power of compounds extracted from various plants. The ABTS radical
scavenging potentials of SPF1-1, SPF2-1, and SPF3-1 are presented in Fig. 4-1C. Result
demonstrates the concentration dependent increase of ABTS radical scavenging activities
of SPFs. And SPF3-1 exhibited higher ABTS radical scavenging ability at all
concentrations tested. The maximum inhibition ability (10.2%, 23.6%, and 57.4%) of
SPF1-1, SPF2-1 and SPF3-1 were obtained at the concentration of 2000 μg/mL, which is
clear that SPF3-1 showed highest ABTS radical scavenging activity.
(4) Reducing power
Reducing power assay always be served as a significant indicator of potential
antioxidant activity of samples. As shown in Fig. 4-1D, the reducing potential of SPF1-1,
SPF2-1, and SPF3-1 increased to 0.14, 0.27 and 0.66, respectively as the concentrations
increased to 4000 μg/mL. However, the positive control trolox showed a stronger reducing
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power (1.36 at 4000 μg/mL) than the polysaccharides examined. These results indicated
that SPF3-1 exhibited a stronger reducing power than SPF1-1 and SPF2-1 and should be
explored as potential antioxidants.
(5) Ferrous ion (Fe2+) chelating capacity assay
Iron induces the formation of free radical by catalysing the conversion of superoxide
radical to toxic hydroxyl radical. As shown in Fig. 4-1E, SPFs have displayed significant
ferrous ion chelating activity in a dose dependent manner. SPF1-1 and SPF2-1 showed a
relatively moderate ability to chelate Fe2+ (29.6% and 38.8%), while SPF3-1 exhibited a
stronger chelating capacity accounting for 63.2% at the concentration of 4000 μg/mL.
(6) Superoxide radical inhibition assay
Superoxide radical is known to produce precursors of hydroxyl radical in vivo,
causing damage to DNA and membrane of cell. Therefore, scavenging ability of
superoxide radical is extremely important to antioxidant research. The superoxide radical
scavenging activity of the obtained polysaccharide fractions and Trolox (VE) were
evaluated and shown in Fig. 4-1F. At a concentration of 62.5-1000 μg/mL, the SPFs
exhibited varying degrees of antioxidant activities with a concentration-dependent manner.
Compared to SPF3-1, SPF1-1 and SPF2-1 had lower levels of superoxide radical
scavenging activities. The highest ability of SPF1-1 (28.7%) and SPF2-1 (46.4%) were
obtained at concentration of 1000 μg/mL. Whereas the inhibition ratio of SPF3-1 reached
to 57.5% at the same tested concentration, significant higher than SPF1-1 and SPF2-1.
4.3.2. In vitro immunomodulatory activities
(1) Macrophages proliferation effect
Macrophage cell is one of the most important immune cells of innate immune system,
always act as the first effector cell to aging cells, pathogens and cancer cells (Sun et al.,
2015). The activation of macrophages has been considered as a primary and necessary step
for immune system stimulation. In the present study, the macrophage cell activation ability
of SPFs was first identified by MTT assay. According to Table. 4-1, the macrophage cell
proliferation of all SPFs-treated groups was significantly stronger than that of blank control
and exhibited remarkable concentration-dependent characteristics. Different with SPF1-1
and SPF2-1, fraction SPF3-1 showed obvious stronger macrophages proliferation effect at
all the concentrations tested, indicating that SPF3-1 may exhibits higher
immunomodulatory activity.
(2) Effects of SPFs on macrophages phagocytosis and NO production
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One of the most distinguished features of macrophage activation would be an increase
in phagocytic activity. In the present study, the immunomodulatory effects of purified
fractions on the phagocytosis of macrophages in vitro were investigated by the uptake of
neutral red. As shown in Fig. 4-2A, all the fractions significantly enhanced macrophage
phagocytosis to various degree in the dose range of 6.25-100 μg/mL, indicated that all the
polysaccharide samples had the abilities to activate macrophages. Obviously, SPF3-1
showed higher phagocytosis stimulating ability, and the extent of stimulation followed the
order SPF3-1 > SPF2-1 > SPF1-1.
As a kind of important molecules produced by macrophages, NO plays a vital role in
the regulation of apoptosis and host defence against pathogens and tumor cells. At the
same time, NO could also enhance the lysis and phagocytosis of macrophages. Thus, the
ability to release NO by macrophages reflects the effects of polysaccharides on immune
function. In this work, a significant increase was detected in NO release in various SPFs
treated macrophages in a dose-dependent manner (Fig. 4-2B). Particularly, the NO
production was 10.40 ± 0.56 μΜ at 100 μg/mL of SPF3-1 treated group, significantly
higher than the SPF1-1 and SPF2-1 group (6.98 ± 0.28 and 8.23 ± 0.39 μΜ).
(3) Protection effect of SPFs on DOX-induced cytotoxicity
DOX always used for cancer treatment, and it has been demonstrated to cytotoxic to
macrophage cell (Li et al., 2016). As shown in Fig. 4-2C, treatment with 0.5 μmol/L DOX
decreased the survival rate of RAW 264.7 cells to 39.58%. While in the presence of SPFs,
the cell viability of RAW 264.7 was significantly increased, reaching to the maximum
(83%, 86%, and 98%) at SPF1-1, SPF2-1, and SPF3-1 concentration of 100 μg/mL,
respectively.
(4) Measurement of SPF3-1 on cytokines production of macrophage cells
Cytokines are small molecular proteins secreted by activated macrophages. They can
mediate and regulate immune response against tumor growth. Among them, TNF-α is a
cytokine which has been recognized as an important host regulatory molecule with tumor
necrosis activity. In addition, as an important regulator of host defense responses, IL-6
contributes to the pathogenesis of various inflammatory and immunologic diseases, also
can produced by activated macrophages. In the present study, according to Fig. 4-3A, the
TNF-α release in the untreated control group was low (97.46 ± 5.40 pg/mL), while the
treatment with 6.25 μg/mL of SPF3-1 resulted in one-fold increase in TNF-α production
compared with the control group. The highest level of 336.82 ± 4.63 pg/mL was obtained
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in 100 μg/mL SPF3-1 treated group, exhibiting no significant difference with the positive
LPS control (356.33 ± 12.64 pg/mL). SPF3-1 also remarkably induced the release of IL-6
in a dose dependent manner at concentrations of 12.5-100 μg/mL (Fig. 4-3B). These results
suggest that SPF3-1 could significantly stimulate the macrophages immune response via
the release of NO and cytokines TNF-α and IL-6.
(5) Cytotoxic effect of SPF3-1 treated macrophages on HT1080 cells
As seen in Fig. 4-4A, the macrophages induced by SPF3-1 significantly reduced the
cell proliferation of HT1080 cells when compared with the control group (p < 0.01). The
maximum inhibition effect (41.5 ± 2.8%) was determined at 100 μg/mL of SPF3-1 treated
group, even higher than the positive LPS group (30.1 ± 2.1%), greatly in agreement with
the above observation on the resultant enhanced macrophages immune response and
phagocytosis capacity against cancer cells after pretreatment with SPF3-1. Meanwhile,
co-incubation with culture media from SPF3-1 treated macrophages resulted in a
significant reduction in cell viability of HT1080 cells (Fig. 4-4B). The above results
demonstrate that after pre-treatment with SPF3-1, the macrophages and culture media
possessed a cytotoxic activity against HT1080 cells. No direct cytotoxic effect of SPF3-1
on HT1080 cell was detected in this work (Fig. 4-4C), indicating that SPF3-1 exhibits an
indirect cytotoxicity on HT1080 cancer cells probably by stimulating macrophages
immune response.
(6) Effects of SPF3-1 on splenic lymphocyte proliferation and cytokines
generation
The immunological activities of SPF3-1 was further investigated by testing its effects
on lymphocyte proliferation in vitro. As shown in Fig. 4-5, SPF3-1 application strongly
promoted the lymphocytes proliferation (p < 0.05) in the concentration ranging from 6.25
to 100 μg/mL, which exhibited a dose dependent manner. The highest viability of
lymphocyte increased to 195.9% after 100 μg/mL of SPF3-1 treatment for 48h, indicating
its potent lymphocyte activation strategy.
In the present study, the effects of SPF3-1 on mouse lymphocytes IL-6 and IFN-γ
were determined with results shown in Fig. 4-6. Clearly, SPF3-1 treatment efficiently
promoted lymphocytes IL-6 and IFN-γ release. At concentration of 100 μg/mL, IL-6 and
IFN-γ production increased to 117.3 ± 25.7 pg/mL and 63.6 ± 8.3 pg/mL, significantly
higher than the control groups (36.8 ± 1.4 pg/mL and 21.0 ± 3.3 pg/mL).
4.4. Discussion
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In this study, in vitro antioxidant activities of separated polysaccharide fractions were
evaluated by detection of DPPH radical, ABTS radical, hydroxyl radical and superoxide
radical scavenging activity, as well as reducing power and ferrous ion chelating activity.
Results reflect that SPF3-1 exhibited higher antioxidant activities, followed by SPF2-1 and
SPF1-1. It is widely believed that the bioactivities of polysaccharides are affected by their
structure characteristics, such as monosaccharide composition, molecular weight, and
chain conformation (Sun et al., 2018). Previous study demonstrated that DPPH radical
scavenging activity showed significant correlations with arabinose content and galactose
content (Zhang et al., 2018). In this study, SPF3-1 contents significant arabinose and
relative higher galactose exhibited strongest DPPH radical scavenging effects. In addition,
the higher galactose and xylose amounts in SPF2-1 and SPF3-1 were found highly
correlated with reducing power and metal chelating activity, this is also confirmed by a
previous study (Zhang et al., 2018).
Molecular weight was one of the most important structure features of polysaccharide.
A number of reports suggested that the antioxidant activity of polysaccharides was also
influenced by Mw. It was supposed that low molecular weight polysaccharides had strong
antioxidant activity (Siu et al., 2016). In the present study, SPF2-1 and SPF3-1 with lower
molecular weight possessed better performances in antioxidant assays, while SPF1-1 had
the highest molecular weight exhibited relatively lowest antioxidant abilities. Generally,
the acidic polysaccharides, which contained a certain amount of uronic acid, were potent
antioxidants. In the present study, SPF3-1 with highest uronic acid content (58.77%),
exhibited strongest antioxidant activities, followed by SPF2-1 (26.92%), and SPF1-1
(12.70%). In summary, this study inferred that the molecular weight, and uronic content
have influences on the antioxidant activity of H. angustifolia polysaccharides, resulting
from SPF3-1 with moderate molecular weight, and highest uronic content exhibited
strongest antioxidant activities.
Phagocytosis is one of the primary features for macrophages response to pathogens
and cancer cells (Liu et al., 2016). Analysis of the phagocytosis capacity of activated
macrophages can reflect the effects of sample on immune function. In the present study,
polysaccharides SPFs were found to significantly enhance the phagocytosis of
macrophages at concentration ranging from 12.5 to 100 μg/mL. Particularly, the resultant
OD value after treatment with 100 μg/mL of SPF3-1 was 0.64 ± 0.04, almost 2 times of the
control group (Fig. 4-2). NO generated by activated macrophages has been identified as
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one of the major effector molecules for the destruction of tumor cells. In this work, a
significant increase in NO release was detected in various SPFs treated macrophages,
which shows a dose-dependent manner (Fig. 4-2B). The NO production was 6.98, 8.23 and
10.4 μΜ at 100 μg/mL of SPF1-1, SPF2-1, and SPF3-1 treated group, significantly higher
than the control group (3.9 μΜ). Since SPF3-1 exhibited highest macrophages activate
activity, SPF3-1 was selected for further immunomodulatory assay identification.
According to Fig. 4-3, the SPF3-1 remarkably induced the release of IL-6 and TNF-α in a
dose-dependent manner.
The immunomodulatory activity of polysaccharides on macrophages is usually
correlated with its structure, monosaccharides composition and molecular weight. Previous
results suggest that polysaccharides are mainly composed of Ara, Xyl, and Gal, and high
content of uronic acid plays a positive role in the stimulation of macrophages (Chen et al.,
2006; Lo et al., 2007; Sun et al., 2015). In this research, SPF3-1 contains highest molar
proportion of Ara (37.3%), Gal (18.2%), Xyl (14.8%) and uronic acid (58.77%, wt%),
SPF3-1 was found to strongly stimulate macrophages immune response. In addition,
polysaccharides from natural plants with lower molecular weight was proven to possess
higher immunomodulatory activities (Xu et al., 2009). In this work, the molecular weight
of SPF3-1 was about 13.36 kDa. Therefore, the significant immunomodulatory towards
macrophage cells of SPF3-1 is most probably attributable to its small molecular weight,
and high contents of Ara, Man, Gal, and uronic acid.
4.5. Summary
All the above findings suggest that fraction SPFs possessed immunomodulatory and
antioxidant activities in certain assays. And the potency of their antioxidant and
immunomodulatory effects can be ordered SPF3-1 > SPF2-1 > SPF1-1. These results
indicated that fraction SPF3-1 has high-efficiency therapeutic antioxidant and
immunomodulatory properties and can be utilized as a new source for functional foods or
drugs.
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Table 4- 1 Macrophage cell proliferation ability (%) of polysaccharide fractions from
HACP
Control 6.25 μg/mL 12.5 μg/mL 25 μg/mL 50 μg/mL 100 μg/mL
SPF1-1 100 ± 3.56 136 ± 4.75 143 ± 7.25 150 ± 9.75 153 ± 5.88 157 ± 4.52
SPF2-1 100 ± 5.25 141 ± 2.68 153 ± 5.61 156 ± 3.54 159 ± 4.95 164 ± 4.56
SPF3-1 100 ± 2.77 155 ± 4.85 169 ± 3.31 172 ± 4.80 183 ± 1.45 193 ± 5.62
Results are represented as mean ± SD, n = 5.
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Figure 4- 1 Antioxidant activities of polysaccharide fractions separated from HACP
(A) DPPH radical scavenging activity; (B) Hydroxyl radical scavenging ability; (C) ABTS
radical scavenging activity; (D) Reducing power; (E) Ferrous ion chelating ability; and (F)
Superoxide radical scavenging ability.
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Figure 4- 2 Activation effects of SPFs on RAW264.7 cells
(A) Effects on macrophages cell phagocytosis activity; (B) Effects of SPFs on
macrophages NO production; and (C) Protection effect on DOX-induced cytotoxicity. The
cells were treated with various concentrations of SPFs or LPS (10 μg/mL) for 24 h. Results
are represented as mean ± SD, n = 5.
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Figure 4- 3 Production of cytokines of macrophage cells treated by SPF3-1
(A) TNF-α production; (B) IL-6 levels of culture supernatant from SPF3-1 treated
macrophages. Results are represented as mean ± SD, n = 5. *p < 0.05, **p < 0.01, and ***p <
0.001 denote statistically significant difference between the treated and control groups.
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Figure 4- 4 SPF3-1 induced cytotoxicity of macrophages against HT1080 tumor cells
(A) Cytotoxicity of SPF3-1 activated RAW264.7 towards HT1080 tumor cells; (B)
Cytotoxic effect of culture supernatant from SPF3-1 treated macrophages; and (C) Effects
of SPF3-1 on HT1080 cell viability. Results are represented as mean ± SD (n = 5). *p <
0.05, **p < 0.01, and ***p < 0.001 denote statistically significant difference between the
treated and control groups.
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Figure 4- 5 Effect of SPF3-1 on splenocytes proliferation of 4T1-bearing mice
Results are represented as mean ± SD (n = 6). NC: normal control, TC: tumor control. *p <
0.05, **p < 0.01, and ***p < 0.001 denote statistically significant difference between the
treated and control groups.
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Figure 4- 6 Effects of SPF3-1 on cytokines production in the culture medium of spleen
lymphocytes
(A) IFN-γ generation; and (B) IL-6 level in culture medium. Results are represented as
mean ± SD (n = 6). NC: normal control, TC: tumor control. *p < 0.05, **p < 0.01, and ***p
< 0.001 denote statistically significant difference between the treated and control groups.
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Chapter 5 Conclusions and perspectives
In this study, the crude polysaccharide HACP was extracted from H. angustifolia, the
in vivo antioxidant and immunomodulatory activity of HACP was evaluated by using a
4T1 tumor-bearing mouse model. The major fractions of HACP were then separated and
structure characterized. Moreover, the in vitro antioxidant and immunomodulatory
activities of purified fractions were further evaluated and discussed.
5.1. Conclusions
The main conclusion of the wok can be summarized as follows:
(1) HACP administration for 15 days significantly enhanced the mice serum
antioxidant enzymes SOD and CAT activity, and increased immune cytokines TNF-α,
IL-1β, and IFN-γ by 3.43, 4.86 and 1.55-fold compared to the tumor control group. The
increased antioxidant ability and immune response in mice resulted in reduced tumor size
with inhibition rates of 34.58 ± 10.20%, 57.80 ± 8.65% and 67.71 ± 5.80%, respectively.
(2) Three major fractions were purified from HACP by using DEAE Sepharose Fast
Flow and Sephacryl S-400 chromatography. SPF1-1, SPF2-1, and SPF3-1 are typical
pectic polysaccharides which contain similar types of monosaccharide, while differ in their
contents. The fraction SPF1-1 is mainly composed of glucose. The main neutral sugars of
SPF2-1 are arabinose and glucose, and for SPF3-1 are rhamnose (Rha), arabinose (Ara)
and galactose (Gal). The molecular weight of SPF1-1, SPF2-1, and SPF3-1 are 279 kD,
15.69 kD, and 13.36 kD, respectively.
(3) With highest inhibition rates against DPPH, ABTS, and superoxide radicals
(74.59%, 57.4%, and 57.5%), and NO, and cytokines IL-6 production (10.40 μΜ and 117.3
pg/mL), SPF3-1 was found to exhibit antioxidant and macrophages stimulation activity.
And the significant efficiency antioxidant and immunomodulatory properties was found to
highly correlated with its highest content of arabinose, galactose, xylose and uronic acid.
Taken together, results from this work revealed that polysaccharides from H.
angustifolia possessed significant antioxidant and immunomodulatory activity both in vitro
and in vivo, it can be used and developed as novel antioxidant and immunomodulatory
therapeutics.
5.2. Future researches
Although polysaccharide SPF3-1 was detected to be effective in antioxidant and
immune response in vitro conditions, its underlying molecular mechanisms and detailed
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structure information still unclear. Therefore, bellow, further studies should be conducted.
(1) The repeating units, sugar sequence, and the degree of branching of SPFs need
further research.
(2) The details on the mechanisms of SPF3-1 on macrophages would be the subject of
continuing study.
(3) Further in vivo immunomodulatory identification of SPF3-1 are necessary.
65
66
References
Aragon, F., Carino, S., Perdigon, G., & Moreno de LeBlanc, A. (2014). The administration
of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an
immunomodulatory effect against a breast tumour in a mouse model. Immunobiology
219(6): 457-464.
Baugh, J. A. & R. Bucala (2001). Mechanisms for modulating TNF alpha in immune and
inflammatory disease Current Opinion Drug Discovery & Develepment 4(5):
635-650.
Berg, J. M., Tymoczko, J. L., & Stryer, L. (2012). Biochemistry. New York, NY: W.H.
Freeman.
Bitter & Muir (1962). A modified uronic acid carbazole reaction. Analytical Biochemistry
4(4): 330-334.
Chang, Y. S., Ku, Y. R., Lin, J. H., Lu, K. L., & Ho, L. K. (2001). Analysis of three lupane
type triterpenoids in Helicteres angustifolia by highperformance liquid
chromatography. Journal of Pharmaceutical and Biomedical Analysis 26: 849-855.
Chen, C. M., Chen, Z. T., & Hong, Y. L. (1990). A mansonone from helicteres angustifolia.
Phytochemistry 29(3): 980-982.
Chen, W., Tang, W., Lou, L., & Zhao, W. (2006). Pregnane, coumarin and lupane
derivatives and cytotoxic constituents from Helicteres angustifolia. Phytochemistry
67(10): 1041-1047.
Cheng, A. W., Wan, F. C., Wang, J. Q., Jin, Z. Y., & Xu, X. M. (2008). Macrophage
immunomodulatory activity of polysaccharides isolated from Glycyrrhiza uralensis
fish. International Immunopharmacology 8: 43-50.
Chidewe, C. K., Chirukamare, P., Nyanga, L. K., Zvidzai, C. J., & Chitindingu, K. (2016).
Phytochemical Constituents and the Effect of Processing on Antioxidant Properties of
Seeds of an Underutilized Wild LegumeBauhinia Petersiana. Journal of Food
Biochemistry 40(3): 326-334.
Cho, W. C. S. & Leung, K. N. (2007). In vitro and in vivo anti-tumor effects of Astragalus
membranaceus. Cancer Letters 252(1): 43-54.
Collins, A., Yuan, L., Kiefer, T. L., Cheng, Q., Lai, L., & Hill, S. M. (2003).
Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells
inhibits mammary tumor formation in nude mice. Cancer Letters 189: 49-57.
67
Cristina Diaz, A., Laura Espino, M., Arzoz, N. S., Maria Velurtas, S., Andrea Ponce, N. M.,
Stortz, C. A., et al. (2017). Free radical scavenging activity of extracts from seaweeds
Macrocystis pyrifera and Undaria pinnatifida: Applications as functional food in the
diet of prawn Artemesia longinaris. Latin American Journal of Aquatic Research
45(1): 104-112.
Debnath, T., Park,P.-J., Deb Nath, N. C., Samad, N. B., Park, H. W., & Lim, B. O. (2011).
Antioxidant activity of Gardenia jasminoides Ellis fruit extracts. Food Chemistry
128(3): 697-703.
Di, T., Chen, G. J., Sun, Y., Ou, S. Y., Zeng, X. X., & Ye, H. (2017). Antioxidant and
immunostimulating activities in vitro of sulfated polysaccharides isolated from
Gracilaria rubra. Journal of Functional Foods 28: 64-75.
DuBois, M., Gilles, K., Hamilton, J., Rebers, P., & Smith, F. (1956). Colorimetric method
for determination of sugars and related substances. Analytical Chemistry 28(3):
350-356.
Ferreira, S. S., Passos, C. P., Madureiea, P., Vilnova, M., Coimbra, M. A. (2015).
Structure-function relationships of immunostmulatory polysaccharides: A review.
Carbohydrate Polymers 132: 378-396.
Ginsburg, O., Bray, F., Coleman, M. P., Vanderpuye, V., Eniu,A.,. Kotha, S. R., Sarker, M.,
Huong, T. T., & Conteh, L. (2017). The global burden of women’s cancers: a grand
challenge in global health. The Lancet 389(10071): 847-860.
Gnanasambanda, R. (2000). Determination of pectin degree of esterification by diffuse
reflectance Fourier transform infrared spectroscopy. Food Chemistry 68(3): 327-332.
Gupta, R. K., Patel, A. K., Kumari, R., Chugh, S., Shrivastav, C., Mehra, S., & Sharma, A.
N. (2012). Interactions between Oxidative Stress, Lipid Profile and Antioxidants in
Breast Cancer: A Case Control Study. Asian Pacific Journal of Cancer Prevention
13(12): 6295-6298.
Harlev, E., Nevo, E., Lansky, E. P., Ofir, R., & Bishayee, A. (2012). Anticancer potential
of aloes: Antioxidant, antiproliferative, and immunostimulatory attributes. Planta
Medica, 78(9):843–852.
Hu, H., Liang, H. & Wu, Y. (2015). Isolation, purification and structural characterization
of polysaccharide from Acanthopanax brachypus. Carbohydrate Polymers 127:
94-100.
68
Huang, C., Cao, X. Y., Chen, X. F., Fu, Y. P., Zhu, Y. G., Chen, Z. L., Luo, Q. H., Li, L. X.,
Song, X., Jia, R. Y., Yin, Z. Q., Feng, B., & Zou, Y. F. (2017). A pectic polysaccharide
from Ligusticum chuanxiong promotes intestine antioxidant defense in aged mice.
Carbohydrate Polymers 174: 915-922.
Huang, F., Zhang, R., Liu, Y., Xiao, J., Liu, L., Wei, Z., Yi, Y., Zhang M., & Liu, D. (2016).
Dietary litchi pulp polysaccharides could enhance immunomodulatory and
antioxidant effects in mice. International Journal of Biological Macromolecules 92:
1067-1073.
Huang, Q., Huang, R., Wei, L., Chen, Y., Lv, S., Liang, C., Zhang, X., Yin, F., Li, H., Zhuo,
L.,& Lin, X., (2013). Antiviral activity of methyl helicterate isolated from Helicteres
angustifolia (Sterculiaceae) against hepatitis B virus. Antiviral Research 100:
373-381.
Jantan, I., Ahmad, W., & Bukhari, S. N. A. (2015). Plant-derived immunomodulators: an
insight on their preclinical evaluation and clinical trials. Frontiers in Plant Science 6.
Jiang, C. X., Zhao, L., Li, S. L., Zhao, X. R., Zhang, Q. H., & Xiong, Q. P. (2013).
Preliminary characterization and immunostimulatory activity of polysaccharides from
Glossaulax didyma. Food and Chemical Toxicology 62(1): 226-230.
Jin, M., Huang, Q., Zhao, K., & Shang, P. (2013). Biological activities and potential health
benefit effects of polysaccharides isolated from Lycium barbarum L. International
Journal of Biological Macromolecules 54: 16-23.
Jin, M., Huang, Q., Zhao, K., & Shang, P. (2013). Biological activities and potential health
benefit effects of polysaccharides isolated from Lycium barbarum L. International
Journal of Biological Macromolecules 54: 16–23.
Klosterhoff, R. R., Bark, J. M., Glanzel, N. M., Iacomini, M., Martinez, G. R.,
Winnischofer, S. M. B., & Cordeiro, L. M. C. (2018). Structure and intracellular
antioxidant activity of pectic polysaccharide from acerola (Malpighia emarginata).
International Journal of Biological Macromolecules 106: 473-480.
Li, K., Lei, Z., Hu, X., Sun, S., Li, S., & Zhang, Z. (2015). In vitro and in vivo bioactivities
of aqueous and ethanol extracts from Helicteres angustifolia L. root. Journal of
Ethnopharmacology 172: 61-69.
Li, K., Yang, X., Hu, X., Han, C., Lei, Z., & Zhang, Z. (2016). In vitro antioxidant,
immunomodulatory and anticancer activities of two fractions of aqueous extract from
69
Helicteres angustifolia L. root. Journal of the Taiwan Institute of Chemical Engineers
61: 75-82.
Li, S., Gao, A., Dong, S., Chen, Y., Sun, S., Lei, Z. & Zhang, Z. (2017). Purification,
antitumor and immunomodulatory activity of polysaccharides from soybean residue
fermented with Morchella esculenta. International Journal of Biological
Macromolecules 96: 26-34.
Li, T., & Peng, T. (2013). Traditional Chinese herbal medicine as a source of molecules
with antiviral activity. Antiviral Research 97(1): 1–9.
Li, Y., Xu, F., Zheng, M., Xi, X., Cui, X., & Han, C. (2018). Maca polysaccharides: A
review of compositions, isolation, therapeutics and prospects. International Journal
of Biological Macromolecules 111: 894-902.
Liu, J., Willfor, S., & Xu, C. (2015). A review of bioactive plant polysaccharides:
Biological activities, functionalization, and biomedical applications. Bioactive
Carbohydrtes and Detary Fibre 5: 31-61.
Liu, W., Wang, H., Yu, J., Liu, Y., Lu, W., Chai, Y., Liu, C., Pan, C., Yao, W., & Gao, X.
(2016). Structure, chain conformation, and immunomodulatory activity of the
polysaccharide purified from Bacillus Calmette Guerin formulation. Carbohydrate
Polymers 150: 149-158.
Liu, X., Xie, J., Jia, S., Huang, L., Wang, Z., Li, C., & Xie, M. (2017). Immunomodulatory
effects of an acetylated Cyclocarya paliurus polysaccharide on murine macrophages
RAW264.7. International Journal of Biological Macromolecules 98: 576-581.
Liu, Y., Huang, G., & Hu, J. (2018). Extraction, characterisation and antioxidant activity
of polysaccharides from Chinese watermelon. International Journal of Biological
Macromolecules 111: 1304-1307.
Lo, T. C., Jiang, Y. H., Chao, A. L., & Chang, C. A. (2007). Use of statistical methods to
find the polysaccharide structural characteristics and the relationships between
monosaccharide composition ratio and macrophage stimulatory activity of regionally
different strains of Lentinula edodes. Analytic Chimica Acta 584(1): 50-56.
Luo, K. W., Yue, G. G., Ko, C. H., Lee, J. K., Gao, S., Li, L. F., Li, G., Fung, K. P., Leung,
P. C., & Lau, C. B. (2014). In vivo and in vitro anti-tumor and anti-metastasis effects
of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma.
Phytomedicine 21: 1078-1087.
70
Mao, G. H., Ren, Y., Feng, W. W., Li, Q., Wu, H. Y., Jin, D., Zhao, T. C. Q., Xu, L. Q., &
Wu, X. Y. (2015). Antitumor and immunomodulatory activity of a water-soluble
polysaccharide from Grifola frondosa. Carbohydrate Polymers 134: 406-412.
Meng, X., Liang, H., & Luo, L. (2016). Antitumor polysaccharides from mushrooms: a
review on the structural characteristics, antitumor mechanisms and
immunomodulating activities. Carbohydrate Research 424: 30-41.
Metcalfe, N. B. & Alonso-Alvarez, C. (2010). Oxidative stress as a life-history constraint:
the role of reactive oxygen species in shaping phenotypes from conception to death.
Functional Ecology 24(5): 984-996.
Morgan, W. T. J. (1936). Studies in immuno-chemistry. I. The preparation and properties
of a specific polysaccharide from B. dysenteriae (Shiga). Biochemical Journal 30:
909-925.
Murk, D. D., Silvestrini, B., & Cheng Y. (2002). Antioxidant superoxide dismutase-a
reviewits function, regulation in the testis, and role in male fertility. Contraception 65:
305-311.
Nie, C., Zhu, P., Ma, S., Wang, M. & Hu, Y. (2018). Purification, characterization and
immunomodulatory activity of polysaccharides from stem lettuce. Carbohydrate
Polymers 188: 236-242.
Pan, H. H., Han, Y. Y., Huang, J. G., Yu, X. T., Jiao, C. W., Yang, X. B., Dhaliwal, P., Xie,
Y. Z., & Yang, B. B. (2015). Purification and identification of a polysaccharide from
medicinal Amauroderma rude with immunomodulatory activity and inhibitory effect
on tumor growth. Oncotarget 10(6): 17777-17791.
Pan, M. H., Chen, C. M., Lee, S. W., and Chen, Z. T. (2008). Cytotoxic triterpenoids from
the root bark of Helicteres anguatifolia. Chemistry & Biodiversity 565-574.
Ramberg, J. E., Nelson, E. D., & Sinnott, R. A. (2010). Immunomodulatory dietary
polysaccharides: A systematic review of the literature. Nutrition Journal 9: 54.
Razali, F. N., Sinniah, S. K., Hussin, H., Zainal Abidin, N., & Shuib, A. S. (2016). Tumor
suppression effect of Solanum nigrum polysaccharide fraction on Breast cancer via
immunomodulation. International Journal of Biological Macromolecules 92:
185-193.
Ren, L., Perera, C., & Hemar, Y. (2012). Antitumor activity of mushroom
polysaccharides: a review. Food & Function 3(11): 1118-1130.
71
Sarangarajan, R., Meera, S., Rukkumani, R., Sankar, P., & Anuradha, G. (2017).
Antioxidants: Friend or foe? Asian Pacific Journal of Tropical Medicine 10(12):
1111-1116.
Schepetkin, I. A. & Quinn, M. T. (2006). Botanical polysaccharides: macrophage
immunomodulation and therapeutic potential. International Immunopharmacology
6(3): 317-333.
Schepetkin, I. A., & Quinn, M. T. (2006). Botanical polysaccharides: Macrophage
immunomodulation and therapeutic potential. International Immunopharmacology 6:
317-333.
Schepetkin, I. A., Faulkner, C. L., Nelson-Overton, L. K., Wiley, J. A., & Quinn, M. T.
(2005). Macrophage immunomodulatory activity of polysaccharides isolated from
Juniperus scopolorum. International Immunopharmacology 5(13-14): 1783-1799.
Shen, C. Y., Jiang, J. G., Li, M. Q., Zheng, C. Y., & Zhu, W. (2017). Structural
characterization and immunomodulatory activity of novel polysaccharides from
Citrus aurantium Linn. variant amara Engl. Journal of Functional Foods 35:
352-362.
Shen, H., Tang, G., Zeng, G., Yang, Y., Cai, X., Li, D., Liu, H., & Zhou, N. (2013).
Purification and characterization of an antitumor polysaccharide from Portulaca
oleracea L. Carbohydrate Polymers 93(2): 395-400.
Shi, L. (2016). Bioactivities, isolation and purification methods of polysaccharides from
natural products: A review. International Journal of Biological Macromolecules
92:37-48.
Siu, K. C., Xu, L., Chen, X., & Wu, J. Y. (2016). Molecular properties and antioxidant
activities of polysaccharides isolated from alkaline extract of wild Armillaria ostoyae
mushrooms. Carbohydrate Polymers 137: 739-746.
Smirnoff, N., Cumbes, Q.J., 1989. Hydroxyl radical scavenging activity of compatible
solutes. Phytochemistry 28: 1057-1060.
Sun, H., Zhang, J., Chen, F., Chen, X., Zhou, Z., & Wang, H. (2015). Activation of
RAW264.7 macrophages by the polysaccharide from the roots of Actinidia eriantha
and its molecular mechanisms. Carbohydrate Polymers 121: 388-402.
Sun, X., Gao, R. L., Xiong, Y. K., Huang, Q. C. & Xu, M. (2014). Antitumor and
immunomodulatory effects of a water-soluble polysaccharide from Lilii Bulbus in
mice. Carbohydrate Polymers 102: 543-549.
72
Sun, Y., S. Hou, S., Song, B., Zhang, C., Ai, X., & Liu, N. (2018). Impact of acidic, water
and alkaline extraction on structural features, antioxidant activities of Laminaria
japonica polysaccharides. International Journal of Biological Macromolecules
112:985-995.
Tang, W., Hemm, I., & Bertram, B. (2003a). Recent development of antitumor agents from
Chinese herbal medicines. Part II. High molecular compounds(3). Planta Medica
69(3): 193-201.
Tao, K., Fang, M., Alroy, J., &Sahagian, G. G. (2008). Imagable 4T1 model for the study
of late stage breast cancer. BMC Cancer 8: 228.
Telo, S., Halifeoglu, I., & Ozercan, I. H. (2017). Effects of stinging nettle (Urtica Dioica
L.,) on antioxidant enzyme activities in rat model of mammary gland cancer164-170.
Iranian Journal of Pharmaceutical Research 16: 164-170.
Tian, L., Zhao, Y., Guo, C., & Yang, X. (2011). A comparative study on the antioxidant
activities of an acidic polysaccharide and various solvent extracts derived from herbal
Houttuynia cordata. Carbohydrate Polymers 83(2): 537–544.
Tu, J., Sun, H. X., & Ye, Y. P. (2008). Immunomodulatory and antitumor activity of
triterpenoid fractions from the rhizomes of Astilbe chinensis. Journal of
Ethnopharmacology 119(2): 266-271.
Vijayarathna, S., & Sasidharan, S. (2012). Cytotoxicity of methanol extracts of Elaeis
guineensis on MCF-7 and Vero cell lines. Asian Pacific Journal of Tropical
Biomedicine 2(10): 826-829.
Wang M, & Liu, W.(1987). A naphthoquinone from Helicteres angustifolia.
Phytochemistry 26: 578-579.
Wang, C., Feng, L., Su, J., Cui, L., Dan, L., Yan, J., Ding, C., Tan X., & Jia, X. (2017).
Polysaccharides from Epimedium koreanum Nakai with immunomodulatory activity
and inhibitory effect on tumor growth in LLC-bearing mice. Journal of
Ethnopharmacology 207: 8-18.
Wang, G. C., T. Li, Y. R. Wei, Y. B. Zhang, Y. L. Li, S. C. Sze and W. C. Ye (2012). Two
pregnane derivatives and a quinolone alkaloid from Helicteres angustifolia.
Fitoterapia 83(8): 1643-1647.
Wang, H., Liu, Y. M., Qi, Z. M., Wang, S. Y., Liu, S. X., Li, X., et al. (2013). An overview
on natural polysaccharides with antioxidant properties. Current Medicinal Chemistry,
20(23): 2899-2913.
73
Wang, J., Hu, S., Nie, S., Yu, Q., & Xie, M. (2016). Reviews on mechanisms of in vitro
antioxidant activity of polysaccharides. Oxidative Medcine and Cellular Longevity
2016: 5692852.
Wang, W., Zou, Y.， Li, Q.，Mao, R.，Shao, X.，Jin, D., Zheng, D., Zhao, T., Zhu, H.,
Zhang, L., Yang, L., & Wu, X. (2016). Immunomodulatory effects of a
polysaccharide purified from Lepidium meyenii Walp. on macrophages. Process
Biochemistry 51(4): 542-553.
Wang, X., Chen, Q., & Lü, X. (2014). Pectin extracted from apple pomace and citrus peel
by subcritical water. Food Hydrocolloids 38: 129-137.
Wang, Y., Huang, M., Sun, R., & Pan, L. (2015). Extraction, characterization of a Ginseng
fruits polysaccharide and its immune modulating activities in rats with Lewis lung
carcinoma. Carbohydrate Polymers 127: 215-221.
Wang, Z., Xie, J., Yang, Y., Zhang, F., Wang, S., Wu, T., et al. (2017). Sulfated Cyclocarya
paliurus polysaccharides markedly attenuates inflammation and oxidative damage in
lipopolysaccharide-treated macrophage cells and mice. Scientific Reports 7: 40402.
Wei, C. Y., He, P. F., He, L., Ye, Q. Q., Cheng, J. W., Wang, Y. B., Li, W. Q., & Liu, Y.
(2017). Structure characterization and biological activities of a pectic polysaccharide
from cupule of Castanea henryi. International Journal of Biological Macromolecules
8: 35-42.
Xu, H., Yao, L., Sun, H., & Wu, Y. (2009). Chemical composition and antitumor activity
of different polysaccharides from the roots of Actinidia eriantha. Carbohydrate
Polymers 78(2): 316-322.
Yu, X. H., Liu, Y., Wu, X. L., Liu, L. Z., Fu, W., & Song, D. D. (2017). Isolation,
purification, characterization and immunostimulatory activity of polysaccharides
derived from American ginseng. Carbohydrate Polymers 156: 9-18.
Yu, Y., Shen, M., Song, Q. & Xie, J. (2018). Biological activities and pharmaceutical
applications of polysaccharide from natural resources: A review. Carbohydrate
Polymers 183: 91-101.
Yu, Y., Shen, M., Wang, Z., Wang, Y., Xie, M., & Xie, J. (2017). Sulfated polysaccharide
from Cyclocarya paliurus enhances the immunomodulatory activity of macrophages.
Carbohydrate Polymers 174: 669-676.
74
Zeng, W.-C., Sun, Q., Zhang, W.-H., Liao, X.-P., & Shi, B. (2017). Antioxidant activity in
vivo and biological safety evaluation of a novel antioxidant peptide from bovine hair
hydrolysates. Process Biochemistry 56: 193-198.
Zhang, C. H., Yu, Y., Liang, Y. Z., & Chen, X. Q. (2015). Purification, partial
characterization and antioxidant activity of polysaccharides from Glycyrrhiza
uralensis. International Journal of Biological Macromolecules 79: 681-686.
Zhang, J., Sun, R., Wei, H., & Tian, Z. (2005). Antitumor effects of recombinant human
prolactin in human adenocarcinoma-bearing SCID mice with human NK cell
xenograft. International Immunopharmacology 5(2): 417-425.
Zhang, L., Hu, Y., Duan, X., Tang, T., Shen, Y., Hu, B., Liu, A., Chen, H., Li, C., & Liu, Y.
(2018). Characterization and antioxidant activities of polysaccharides from thirteen
boletus mushrooms. International Journal of Biological Macromolecules 113: 1-7.
Zhang, M. M., Wang, G., Lai, F. R., & Wu, H. Structural Characterization and
Immunomodulatory Activity of a Novel Polysaccharide from Lepidium meyenii.
Journal of Agriculture and Food Chemistry 1921-1931.
Zhang, S., Nie, S., Huang, D., Li, W., & Xie, M. (2013). Immunomodulatory effect of
Ganoderma atrum polysaccharide on CT26 tumor-bearing mice. Food & Chemistry
136(3-4): 1213-1219.
Zhang, S., Shao, Q. Q., Shen, Z. H., & Su, S. K. (2017). Immunomodulatory response of
4t1 murine breast cancer model to camellia royal jelly. Biomedical Research 28(3):
1223-1230.
Zhang, S., Wang, Q., Li, W. F., Wang, H. Y., & Zhang, H. J. (2004). Enhanced antitumor
immunity by murine cytokine activated T lymphocytes after cocultured with bone
marrow derived dendritic cells pulsed with whole tumor lysates. Leukemia Research
28(10): 1085-1088.
Zhao, J., Zhang, F., Liu, X., St Ange, K., Zhang, A., Li, Q., & Linhardt, R. J. (2017).
Isolation of a lectin binding rhamnogalacturonan-I containing pectic polysaccharide
from pumpkin. Carbohydrate Polymers 163: 330-336.
Zhu, L., Cao, J., Chen, G., Xu, Y., Lu, J., Fang, F., & Chen, K. (2016). Anti-tumor and
immunomodulatory activities of an exopolysaccharide from Rhizopus nigricans on
CT26 tumor-bearing mice. International Immunopharmacology 36: 218-224.
75
Acknowledgements
I wish to express my sincere appreciation to my principal advisor, Professor Zhenya
Zhang, for his kindly and warmly guidance and encouragement.
I also would like to express my great appreciation to my dissertation committee
members, Professor Zhongfang Lei, Professor Kazuya Shimizu, and Professor Hideaki
Maseda for their numerous suggestions, comments, willingness and helpful discussions to
serve as my advisory committee members.
I would also like to thank all of my friends in the laboratory for their friendship and
contributions. I wish to express my appreciation to Miss Xi Yang, Mr. Long Xiao, and Mr.
Yuepeng Wang, for their countless assistance during the years of my study here.
